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ABSTBACT 
The indiscriminate use of various types of pesticides 
in the modern world has led to much greater emphasis on the 
possibility of serious environmental contamination which is 
a fast developing menace to the survival of mankind. Pesti-
cides threaten the welfare of the poor in the Third World 
countries, because of their free availability, lack of 
adequate protection, improper storage, excessive and wasteful 
use leading to environmental pollution. Ideally, their effects 
should be highly selective in affecting the undesirable target 
animals. However, most of the pesticides that have been 
developed have turned out to be toxic for non-target animals 
too. 
Thus,far, it has been assumed that neurotoxicity of 
organophosphorus pesticides is due to mainly cholinesterase 
inhibition with a subsequent increase of ACh level. But 
recently it has been shown by several researchers that the 
acetylcholine is not the only transmitter involved in the 
organophosphate induced convulsions. The exact mechanism of 
action of organophosphorus compounds is still unclear* It 
would therefore be appropriate to investigate other parameters 
of toxic damage. The lipids comprise more than 5C^ of dry 
weight of the brain and, therefore, it would be worthwhile 
to find out the alterations in the lipid fractions after 
- ii -
organophosphate intoxication. This thesis is designed to 
serve a two-fold purpose: first to out-line the present 
state of our knowledge of lipids and nucleic acids in 
cerebrum, cerebellum, brain stem and spinal cord and second 
to indicate how far metasystox can influence the lipid and 
nucleic acid contents of the different regions of the rat 
brain. The data present the first report of the values of 
the regional brain total lipids, phospholipids, cholesterol,' 
esterified fatty acids,gangliosides, deoxyribonucleic acid 
and ribonucleic acids and the effect of metasystox toxicosis 
thereon. To date, neurochemical studies of regional lipid arid 
nucleic acid changes in the rat brain have not been reported 
in the literature. Experiments to evaluate the neurochemical 
effects of organophosphate metasystox, were performed in the 
following sequence. 
(i) In the first series of experiments rats were given 
metasystox (1,'2 and 4 mg/kg body weight intraperitoneally) 
daily for 10 days. Metasystox-toxicosis produced a significant 
dose-related depletion of total lipids,' cholesterol, esterified 
fatty acids and gangliosides in the cerebral hemisphere, 
cerebellum,' brain stem and spinal cord. Interestingly, the 
phospholipids were unaltered at the dose of 1 mg/kg body 
weight but increment of the dose to 2 and 4 mg/kg body 
weight caused significant diminution of phospholipids in the 
brain stem and cerebellum. The cholesterol/phospholipids 
(C/P) ratio was diminished in cerebral hemisphere, brain 
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stem and spinal cord, but remained unaltered in the region 
of cerebellum. 
The decreased levels of total lipids and phospholipids 
after 10 days administration of metasystox (2 mg/kg body 
weight) to each rat were also demonstrated histochemically 
in the cerebral hemisphere* 
(ii) In the second series of experiments, rate of lipid 
peroxidation and lipase activity were measured after the 
daily administration of metasystox in three different doses 
(1, 2 and 4 mg/kg body weight i.p. 10 days). In metasystox 
intoxicated rats the rate of lipid peroxidation and lipase 
activity exhibited remarkable dose-related increase in all 
the brain areas studied. 
The enhanced activity of enzymes after metasystox 
(2 mg/kg body weight) was also detected quantitatively in the 
rat cerebral hemisphere. 
(iii) In the third series df experiments the effect of 
vitamin E (oC-tocopherol) on the rate of lipid peroxidation 
and lipase activity in the discrete areas of the brain and 
spinal cord were studied. The experimental rats were 
administered oC -tocopherol (150 lU/kg body weight, intra-
peritoneally daily for 10 days) alone and in combination 
with metasystox (2 mg/kg body weight, i.p. daily for 10 days), 
respectively. Administration of oC-tocopherol alone caused 
- iv -
significant reduction of lipid peroxidation and lipase 
activity. lA/Tnen it was administered simultaneously with 
metasystox, X-tocopherol prevented the metasystox-indmced 
increase of lipid peroxidation and lipase activity. 
(iv) In the fourth series of experiments, rats were given 
metasystox (I,"?, and 4 mg/kg body weight, i.p. daily for 
10 days) to evaluate the dose-dependent effects of metasystox 
on the levels of DMA and RNA in cerebrum, cerebellum, brain 
stem and spinal cord. Metasystox (1 mg/kq body weight) signi-
ficantly depleted the content of DNA in all the brain regions. 
This diminution was correspondingly more at the dose of 
2 mg/kg body weight in all the regions, however, when the 
dose was increased to 4 mg/kg the percent decrease was also 
more significant in cerebrum, cerebellum, brain stem and 
spinal cord. The concentration of RNA was also diminished 
in cerebrum whereas increased in rest of the brain regions. 
Diminution in the levels of nucleic acids after meta-
systox (2 mg/kg body weight) administration was also observed 
histochemically in the rat cerebrum. These observations were 
in concurrence with the biochemical findings. 
(v) In the fifth series of experiments an attempt has been 
made to study the alterations in the rate of DNase and RNase 
activities of rat brain regions due to metasystox treatment. 
- V 
The activity of lipase showed dose-dependent elevation in 
different regions of the CNS. On the other hand, the activity 
of RNase showed significant dose-relcted diminution in the 
cerebral hemisphere, and dose-dependent increase in rest of 
the brain regions. 
Analysis of variance indicated that the total variation 
within different regions of the brain is significant* Moreover, 
metasystox-intoxication exerted remarkable effect in the 
regional lipid and nucleic acid profiles of the brain and 
spinal cord* 
The results of all experiments clearly indicate that 
metasystox administration induces dose-related alterations 
of brain lipids and nucleic acids* Diminution in the lipids 
is supported by the increment in the lipid peroxidation and 
the enhanced activity of lipase in different regions of the 
brain and spinal cord. It is clear that the peroxidation of 
endogeneous lipids has been enhanced by organophosphate 
metasystox* Interestingly, the lipid and nucleic acid contents 
are influenced differentially in the various parts of the 
brain* Regional heterogenity is apparent in the concentration 
of lipids and nucleic acids in the various brain regions 
as well. 
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1.0 INTRODUCTION 
1.1.0 Orqanophosphorus Compounds; 
Organophosphates are the group of compounds with various 
toxicities to different forms of life. The widest use of these 
compounds is as insecticides for which purpose organophosphate 
with toxicity relatively high to insects and low to man and 
other mammals are chosen. Organophosphorus compounds may be 
divided into two groups: The first group will inhibit the 
ti ti 
enzymes in vitro, and as a general rule, their activity as 
inhibitors is proportional to their toxicity to mammals. The 
second group may have little or no activity as inhibitors of 
cholinesterase in vitro, but once inside the animal body they 
become changed into active inhibitors of uncertain chemical 
constitution. The original compound is more stable to hydrolysis 
and some of the groups are valuable insecticides. 
Previously some organophosphates have been used medically 
for the management of myasthenia gravis and glaucoma, but this 
use has decreased because of their narrow margin between 
therapeutic and toxic doses. The most toxic of these compounds 
has been stockpiled as nerve-gases for possible use in chemical 
warfare. Some organophosphates are also used as plasticizer 
in plastic industry or as a lubricant and additive e.g. 
? 
hi 
tri-orthocresyl phosphate (TOCP),-diazinon etc. 
According to the W.H.O. report approximately, 1300 
organophosphorus compounds have so far been prepared out of 
which some are not recommended for use due to their high level 
of mammalian toxicity. The yearly production of organophosphate 
is now approaching 100,000 tons. The utility of the organophos-
phate pesticide is undisputed today. It can be expected that 
they will solve many of the World's nutritional problems. These 
compounds form the basis of the large number of insecticides, 
pesticides, nematocides and fungicides widely used in agriculture. 
Therefore, the increasing use of the organophosphate insecticides 
and pesticides offers more challenging areas of study. 
1.2.0 Historical Overview 
Ever since the dawn of civilization, man has been waging 
a ceaseless war for his survival against an army of pests. Many 
weapons were deployed in the war against the ravages caused by 
pests and partial success was achieved in some instances 
(Table - I). 
The organic phosphate pesticides had a rather sinister 
origin. In 1940, a group of German chemists were looking for an 
efficient war gas which would be absorbed through the skin and 
would cause rapid death or incapacity. As a by-product of 
their scientific devotion they synthesized a series of materials 
which we refer to collectively now as the organic phosphate 
pesticides. 
TABLE - 1: Hi s to ry of Development and Use of I n s e c t i c i d e s 
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Remarks Year Chemicals 
Era of natural products 
Era of fumigants, 
inorganics 
Era of modern synthetic 
insecticides 
Era of hormones and 
pharomones 
1690 Use of tobacco, soaps, 
phosphorus and derris 
root etc. 
1854 CS2, Raris green, HCM 
petroleum products, lead 
arsenate etc 
1925 DDT, thiocyanates, BHC, 
organophosphates• 
1967 First hormone mimic 
(juvinile) insecticides, 
DDT trial begins. 
The first organophosphate insecticide was tetraraethyl 
pyrophosphate (TEPP). It was developed in Germany as a 
substitute for nicotine, which was in short supply in that 
countiy during World War II. It is remarkable that the first 
account of the synthesis of TEPP, was publis>hed by Clermont 
in 1854, by alkylating the silver salt of the pyrophosphoric 
acid with alkyl halides. 
S^S ' 
C2H5 -
- 0 .0 
P /v 
. 0 0 
0 . 0 
p 
/ \ 
0 0 
- C^ ,H| 2 5 
- C.,H. 
This ester is the bridge between the inorganic and 
organic chemistry. The insecticidal activity of this compound 
was discovered after 80 years of its synthesis. TEPP, although 
an effective insecticide, was highly toxic to mammals and was 
rapidly hydrolyzed in the presence of moisture. 
Holfmann in 1872 synthesized the corresponding phosphoric 
acid by reacting methyl and ethyl phosphine with nitric acid. 
Subsequently in 1897 Michaelis and Backer synthesized a phosphonic 
acid ester by the reaction of dialkyl phosphite with ethyl iodide. 
This reaction became well known as Michaelis - Backer reaction. 
Further in 1898 Michaelis and Kaehne synthesized another 
compound from tryalkyl phosphite and methyl iodide whose structure 
was not similar to the compound which was obtained by Michaelis-
Backer reaction. Michaelis (1903) again synthesized phosphorus-
nitrogen compounds by the reaction of ammonia or amines with 
phosphorus trichloride, pentachloride, phosphoryl chloride and 
thiophosphoryl chloride. He synthesized N-alkylamino-dichloro-
phosphine (II) by the reaction of phosphorus trichloride with 
alkylaraine, which he later oxidized with chlorine to the 
tetrachlorides (III)» and atmospheric moisture sufficed to 
R2N - PCI2 R^ N - PCI4 
II III 
hydrolyze the tetrachloride to dialkylaminophosphorodichloridates 
(IV). 
5 
0 
1/ II ^ C I 
RoN - P . 
IV 
Subsequently he synthes ized 0 , 0 - d i e t h y l N,N-Diethyl phospho-
roamidate (V) and r e l a t e d compounds. 
\0C2H5 
V 
Modern investigations of the organophosphorus compounds, and 
the first hint of their toxicity, date from the 1932 publi-
cation of Lange and Krueger on the synthesis of dimethyl and 
diethyl phosphorofluoridates (VI). 
RO 
RO F 
VI 
It has been reported that the inhalation of the vapors of 
these compounds cause a persistent choking sensation and 
blurred vision • 
G 
Investigators in the allied countries also followed 
Lange and Krueger's lead in the search for potentially toxic 
compounds; diisopropyl phosphorofluoridate (DFP) synthesized 
by McCombie and Saunders (1946), was the organophosphorus 
compound studied most extensively by British and American 
Scientists* They also described the miotic and high inhalation 
toxicity of these compounds. 
i-CcHvO .0 
\ / / 
/ \ 
i-CgH^O F 
VII 
During the synthesis and investigations of approximately 
200 compounds, Scrader (1952) defined the structural requirements 
for insecticidal activity. One compound in this early series, 
"parathion" (VIII) later became the most widely employed 
insecticide of this class. 
S 
^'^'^cp)^ - P - 0 - / o \ - NO2 
VIII 
Shortly after parathion became available for study. 
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acute toxicity studies on experimental animals revealed signs 
of poisoning that resembled excessive stimulation of cholinergic 
nerves. 
During the last two decades the agricultural chemistry 
industry has developed many other organic triesters of phos-
phoric acid and phosphorothioic acid that have been registered 
for use. In the same period {i960) in Germany, oxydemeton-methyl 
(Metasystox) was first introduced as a separate compound by the 
Bayer-Levekusen Company* 
0 0 
CH3O 
X l l II 
/ 
cV\ 
P - S-CH2 - CH2 - S - C2H5 
IX 
Since, then numerous studies have been conducted on metasystox 
because of its wide use as an agricultural insecticide. 
1.3.0 Nomenclature; 
Several years ago there were four different "official" 
systems for nomenclature:competing British, Swedish, German 
and American systems. Fortunately, Anglo-American agreement 
was reached in 1952 for the naming of the compounds containing 
one atom of phosphorus and these make up the great majority of 
economic compounds. But the old habits die hard, and the 
n 
"international" system is not universally used. 
The compounds are complex in structure, and it is often 
convenient to use a different part of the molecule as the key 
in closely related molecules. It does however, lead to situations 
in which, e.g. (EtO)2 Po. S. CH2«CH2*^^'^ (Demeton-S), is named 
0,0-diethyl S-2-ethylthioethyl phosphorothiolate, and (EtO)^ 
PO.S.CK^.CHp.SEtp, its ethylsulphonium derivative is named 
2-(diethyoxyphosphinylthio)-ethyldiethyl sulphonium ion. Much 
can, however, be done by the systematic use of trivial or 
shortened systematic names and here the following rules are 
adhered to (Heaths, 1961). 
At the first mention of each compound the structural 
formula is given, and either its systematic name on the Anglo-
American system, or a brief name. Brief names have been chosen 
from those in common use and have been taken from the Journal 
of Economic Ei}tamology or British Standards. 
Groups of compounds are, when considered together, 
given group names, based on the Anglo-American system (Table-2 ). 
The distinction between PS and P.S.C. compounds is made by 
calling the former thionates and latter thiolates. The alter-
native, in which both are called thioates, but the substituents 
are prefixed by 0- or S-, is only unambiguous if these substi-
tuents are named, which is inconveninet. Thus 0,0-diethyl 
S-ethylphosphorothioate is unambiguous, but if for brevity 
9 
TABLE - 2 : Chemical Structures. Name of the Compounds and 
Group Names 
Structure Name of type Group name 
(R0)2P0.R 
(R0)3P0 
(R0)2PS.R 
(ROgPS 
(RO) {R)PO.SR 
(R0)2P0.SR. 
(RO^PS.SR 
(R0)2P0.0K 
(ROJ^POSH* 
(R0)2PS.SH 
R2PO.F 
(RO) (R)PO,F 
(R0)2P0.F 
(RNH)2P0.F 
(R2N)2P0«F» 
(RO) (R2N)P0.F. 
phosphonates 
phosphates 
phosphonothionates 
phosphorothionates 
phosphonothiolates 
phosphorothiolates 
phsophorodithioates 
hydrogen phosphates 
hydrogen phosphorothioates 
hydrogen phosphorodithio-
ates 
phosphinofluoridates 
phosphonofluoridates 
phosphorofluoridates 
phorphorodiamidic 
fluorides 
phosphoramidofluoridates 
phosphonates 
phosphates 
thionates 
thiolates 
dithioates 
hydrogen phosphates 
hydrogen thioates 
hydrogen dithioates 
fluoridates 
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the 'ethyls' are omitted, phosphorothioate includes both triethyl 
phosphorothiolate, (EtO)2PS. 
Where a thionate has a trivial name ending in "thion", the 
phosphate analogue is given the same prefix but the ending 'oxon'* 
Thus (Et0)2pS.0.C^H4-4-N02 is Parathion, and (Et0)2P0.0.C^H4-4-N02 
is Paraoxon. Most of the names formed in this way are accepted 
names, when the oxygen analogue would have a particularly unpro-
nounceable name, as Gu-Oxon from Guthion, the 't' is retained, 
giving Gutoxon. When a trivial name exists for one member of a 
homologous series, other members in which both basic groups are 
changed are named by putting the formula of the basic group as a 
suffix to the trivial name. 
The multiplicity of organophosphates frequently causes them 
to be victims of confusion between common and proprietory names. 
A proprietory name is the one usually allocated by the company 
which owns the compound; it should always be used with a capital 
letter and is often followed by an R to show that it is registered 
trade mark. 
1 • 3.1 Netaenclatare. of Isomers 
Some of the organic phosphorus insecticides contain two 
asymmetrically substituted, nonterminal atoms joined by a double 
bond and therefore, occur in two stereoisomeric forms. 
It sometimes has occurred that the isomers of a compound 
were at least partially separated, characterized entomologically 
11 
or in some other way, and designated alpha~ and beta- before 
the orientation of their moieties had been defined. 
When the orientation was learned the two forms "cis" and 
"trans" were designated respectively. In considering the 
orientation of similar moieties in space across the double bond, 
emphasis generally was placed on carbon chains, but the rules 
were not precise or failed to cover some situations. This 
became a source of confusion in organic chemistry. The problem 
was in no way restricted to phsophorus compounds and had no 
special implications for toxicology. 
A rigid set of rules was developed for determining which 
moiety on one side of a plane is to be compared to which moiety 
on the other side. Rather than imposing the new rule on the 
old terms, new terras were used, presumably on the basis that 
new wine ought to be put into new bottles. The new terms are 
Z (from the German Zusammen, meaning together), and E (from 
entgegen, meaning opposite). The entire matter has been dis-
cussed in great detail by the International Union for Pure and 
Applied Chemistry (lUPAC, 1970). Unfortunately the new rules 
for defining the precedence of moieties sometimes are opposite 
to earlier custom. The result is that some isomers formerly 
designated "cis" are now correctly designated "E", even 
though the terms themselves have opposite meanings. Examples 
include the isomers of monocrotophos, dicrotophos, mevinphos 
and phosphamidon. 
n 
1.4.0 Classification of Orqanophosphorus Compounds; 
No chemical classification has been proposed that will 
divide this wide variety of organophosphorus compounds into 
pharmacologically and toxicologically homogeneous groups with 
no overlapping. 
According to Holmsted (1959), Schrader noted as early 
as 1937 that the general formula for anticholinesterase organic 
phosphorus compounds is 
R, 0(or S) 
in which X is the leaving group. All the compounds may be 
placed in four main categories, depending on the character of 
the X - constituent, as follows: 
( I ) X contains a quaternary nitrogen 
( II ) X = F 
(III) X = CN, OCN, SCN, or a halogen other than F 
( IV ) X = Other moieties (Table-3). 
The first of these categories are small. Although categories 
II and III are somewhat larger, only a ver^ r few compounds in 
one of them (II) have been used or even considered as pesticides. 
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TABLE - 3 : Examples of the Four Main Categories of Organic 
Phosphorus Compounds 
Group X-constituents Example 
substituted 
quaternary 
nitrogen 
C2H^-0 0 
P 
/ \ 
C2H5-O S-CH2-CH2-N '^- (CH3) 3 
ecothiopate iodide 
II 
III 
IV 
CN, OCN, SCN, 
or halogen other 
than F 
CH, 
CH 
CH-0 0 
3 \ 
CH3 F 
(iC3H^ 0)2P(0)-.F 
CH, 
\ 
CH. 
C2H5-O 
C^H^. 0 alkyl, alkoxy or 
alkylthio; aryl 
or heterocyclic; 
aryloxy, arylthio, 
or one of their 
heterocyclic 
analogs;nitrogen; C»H^- 0 
or disubstituted ^^ 
phosphoryl groups ^Y—^Ov. /O 
\ / 
A 
C^ J 
S 
sarin 
DFP 
tabun 
parathion 
^^ V 
CH3 P ^ C*^ triorthocresyl 
y^ ^ Q » ^ ^ phosphate 1 ^ 0 
CH. 
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There seems to be no need to subdivide these categories at this 
time. On the other hand, category IV may be subdivided usefully 
into at least eight groups on the basis of their Rj^  - and R2 -
constituents* Several of these groups differ either quantita-
tively or qualitatively in toxicity* In each of the first seven 
groups Ri af^ci R^ are identical, with the exception that thioisomers 
formed by rearrangement of certain compounds are also classified 
as belonging to the parent group. For example, isomalathion, 
S-methyl isomer. 
In the last group (mixed constituent compounds), R, and R^ 
are different. In many compounds of this group,' all four 
substitutions on the phosphorus are different and the compound 
is optically active. However, there are exceptions, in which the 
X-group or leaving group is identical to one of the R-groups, 
and the compound is not optically active. 
l.'S.O Structure Activity Relationship; 
There is a relation between the activity and chemical 
structure of organophosphorus compounds. Slight change in the 
chemical structure greatly alter the entire spectrum of bio-
logical activity. The effects of the structures of inhibitors 
on the rates at which they inhibit enzyme have only been 
investigated in any detail on ChE's. Inhibition of ChE's is 
therefore considered first. A phosphorus inhibitor contains 
three types of group; 
Id 
B. VI 
p ' 
B'^ X 
the basic or neutral 'B' groups, the acidic group, X, and the 
atom from the sixth period of the periodic table, usually 
oxygen or sulphur, doubly bonded to the phosphorus. Each type 
of group has a typical effect on activity. In addition there 
are certain steric and charge effects. 
1.5.1 Basic Groups: Change in the basic groups in phosphorus 
compounds, produces a complex variation in rates of 
inhibition, and this variation is different according 
to whether the enzyme inhibited is an AChE or a ChE. 
There is no general relationship between the rates 
at which compounds are hydrolyzed and the rates at which 
they inhibit ChE's, because the effects of the basic 
groups on hydrolysis rates are mainly 'electronic', 
and on rates of inhibition mainly 'steric'. 
1.5.2 Acidic Groups; When changes in structures are confined 
to the acidic group, X, there is generally close 
correlation between rates of hydrolysis and rates of 
inhibition. Rates of hydrolysis depend primarily on 
the strength of the acidic, HX. Exceptions are 
cyanidates, thiolates, and phosphate esters containing 
J.G 
vicinyl double bonds (P.O.C:C), which hydrolyse abnormally 
rapidly. 
1,5,3 P;0 and P;S Groups: Thionates isomerize or are oxidized 
readily to more active compounds. The P 50 of 'parathion' 
is thus about 4 less than the P'^ SO of its oxygen analogue, 
'paraoxon', i.e. paraoxon reacts about 10,000 times 
faster. Perhaps the P=0 oxygen in phosphates is hydrogen 
bonded to the enzyme surface, and this facilitates the 
reaction. Sulphur has much less ability to form hydrogen 
bonds, so the thionates react more slowly. It is inte-
resting in this respect that the thiono-analogues of ACh 
and related esters are not hydrolysed by AChE and other 
esterases (Bergmann et al. 1958). 
Biological activity of organophosphorus compounds 
therefore, vary according to the change in structure or 
even the change in the same group as shown in Table-4. 
TABLE - 4 : Structure and Neurotoxic Action of Different 
Organophosphorus Compounds 
Neurotoxic Non-Neurotoxic References 
CH 3 
(O-o-I P 0 
/h»S (O-l P 0 
/ .C2H5 
{Q-'{- 0 
BONDY et al.,1961. 
ALDRID6E BARNES 1961. 
BONDY e t a l . 1960 
- f 
i 'J 
/^"3 
f ? _ J ^ - 0 - ) j P=0 ("3'^'^3'° ' )3 ^=° ALDRID6E 8 BARNES,1961 
(c2H5-Q-0 - )3P=0 / 2 " 5 (O-) 3 P::0 ALDRID6E & BARNES;1961 
ALDRIOGE& BARNES, 1966 
CH3(CH3)4 
Cl{CH2)2 0 0 C2H5O 0 
\p '^ ^ p ' ^ ALDRIDGE & BARNES, 1966 
Cl{CH2)20 0 - \ 7 NO C2H5O 0-/^)- NO 
P P BARNES & DENZJ935 
/ \ / \ 
iC3H7 NH F (CH3)2N ^ 
0 0 
jr H,0 0 iC.H^Oll II OCHi DAVISON, 1953 
iCjH^O F IC3H7O OCjH,! 
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1.6.0 Mechanism of Action of Orqanophosphorus Compounds; 
1.6.1 Molecular Mechanism of Action; The most significant and 
unambiguous molecular mechanism of action universally 
accepted as the model for enzyme inhibition studies is 
the action of organophosphates through phosphorylation 
of the hydroxyl groups of serine in the active site of 
the vital enzyme acetylcholine esterase (AChE) of the 
target organism. A scheme for substrate and inhibitor 
interactions with acetylcholinesterase is shown in Fig. 1. 
The overall reaction can be illustrated by considering 
the organophosphate insecticides as substrates; 
K 
EOH + AX 1 X 
K, 
X K ~ 1 
EOA 
EOH. AX -> X + H 
"2° 
-^ EOH + A" + H* 
ACETYL CHOLINESTERASE (AChE) 
ANIONIC SITE ESTERIC SITE G = ACTIVE CENTER 
SERINE 
-glu - NH - CH - CO - ala 
CH2 
OH 
ACTIVE CENTER 
to^^^^ 
X ^^^M 
1 ^^K>l<>K>K 
1 ^ « » ^ « ^ 
0 = 0 ^ 
^^ -^ 1 0 -0 x^iU 
1 j i ^ ^ . 
^ / ^ ^ ^ X I M S ^ 
0 \ ^ © © ^ 
1 NQ^M^ 
X ^ 
0 ^ 
1 ^ 
0 \^g§©^ 
1 /^  
1 1 
» 
0 
h-
< Hi 
^<f) 
( / ) 
LU 
0 
Z U J 
O H 
Z C/5 
X 
0 
0 
0 
K> 
X 
0 
+ 
X 
0 
CVJ 
X 
0 
CM 
X 
0 
^ +2 
0 
N 
LU 
CL 
O 
CO 
CO 
CO 
^ % 
o 2 
o 
O CO 
cd ^ 
o 
> > 
E 
O O 
O — 
.E o 
CO .«» 
c 
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> x: 
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^ 
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There are three important steps in the reaction - (l) Complex 
formation, (2) Phosphorylation, (3) Dephosphorylation. 
Complex formation is governed by an afinity constant Ka 
(i.e. K - 1/K,). This is quite small for the organophosphate 
insecticides as well as the natural substrate acetylcholine; 
therefore, the enzyme substrate or enzyme inhibitor complex 
(EOH.AX) is favoured. With acetylcholine K^ and K^ are very 
fast so that total reaction occurs rapidly and new enzyme is 
regenerated. With organic phosphates is moderately fast, but 
Ko is extremely slow; so EOA accumulates while EOX.AX is minimal. 
The third step (K3) is the most critical and slowest. 
To summarize, phosphorus inhibitors react chemically with 
the enzymes, they inhibit by phosphorylation of them. The 
reaction is progressive (amount of reaction(inhibition) 
increases with time), non-competitive and not readily reversed. 
Reaction may be preceded by the formation of an adsorption 
complex, but, if so, the complex is very unstable. 
1»6,»2 Mechanism of Nerve Transmission; The central role of 
AChE inhibition in the mode of action of many systemic 
insecticides and the involvement of some phase of nervous 
activity in their residual toxicity to the non-target 
mammalian system, make it obligatory to appreciate the 
elementary mechanistics of synaptic transmission. 
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The central nervous system is made up of brain and spinal 
cord. CNS communicates with the rest of the body by the 
peripheral nervous system. The communication channel is through 
cable lines of axon made up of innumerable neurons (Structural 
and functional unit of the nervous system)* 
The transmission of the nervous impulse is an electro-
physiological process in which the current is carried by 
monovalent ions (Fig. 2). Propagation of nerve impulse coin-
cides with changes in the permeability of the axon membrane. 
The axon interior is rich in potassium and poor in sodium ions; 
the fluid outside has, however, a reverse composition. When 
a nerve impulse is generated, a flood-gate opens and lets sodium 
ions pour into the axon making the interior mileu locally 
positive. Follov/ing the impulse, the "sodium gate" closes and 
opens a "potassium gate" allowing potassium to efflux out, 
restoring the normal negative potential (Castillodel and Kotz, 
1957; Eccles, 1957). Between the meeting point of a neuron 
and an axon is the synaptic junction 20-30 nm wide. The 
electrical impulse is sent across by chemical transmitters. 
The arrival of the nerve impulse at presynaptic membrane 
triggers the release of acetylcholine from "vesicles" or 
storage sites located in presynaptic cells. After passage 
across the synaptic cleft, acetylcholine gets itself attached 
to a "binding site" on the post-synaptic cell (Fig. 3 ). The 
liberated acetylcholine is not allowed to stay too long in the free 
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state and is immediately broken down to acetic acid choline by 
the hydrolytic enzyme acetylcholinesterase. 
The inhibition of acetylcholinesterase leads to the 
accumulation of acetylcholine and prevents the smooth trans-
mission of nervous impulses across the synaptic gap. The 
resulting disturbances in electrophysiology cause loss of 
muscular coordination, induction of convulsions and ultimately 
death. 
1.7.0 Neurotoxicity of Qrqanophosphorus Compounds 
Some organophosphate pesticides do constitute a serious 
threat of neurotoxicity. Numerous research programs have been 
directed towards an understanding of the structural requirements 
of these neurotoxic esters (Davies et al., i960; Abou-Donia, 
1979). It was found that some compounds that produce moderate, 
inhibition of cholinesterase are neurotoxic while others that 
produce profound prolonged inhibition are not neurotoxic. When 
neurotoxicity occurs, its course does not parallel the degree 
of cholinesterase inhibition (Cavanagh, 1964; 1973). The 
idea that inhibition of cholinesterase is related to neuro-
toxicity, has been dropped (Aldridge and Barnes, 1966b), but 
it is difficult to abandon the idea that some antiesterase 
activity is of importance. 
The esterase that is phosphorylated by neurotoxic organic 
phosphorus compounds has been called "Neurotoxic esterase"(NTE) 
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(Johnson, 1969b). Some compounds are direct inhibitors of 
NTE, others are indirect inhibitors, requiring metabolic 
change in order to become active. For example, activation 
of neurotoxic phosphonothionates to the phosphonates is 
required before they are active inhibitors of NTE {Johnson^975) 
All neurotoxic compounds examined by the test cause 75% 
or more inhibition of NTE, usually within 24 hours (Johnson, 
1975a). The NTE, test has been made both more selective and 
sensitive and also easier to perform (Johnson, 1977). There 
is a good correlation between the in vitro reactivity of brain 
neurotoxic esterases derived from hens and people (Lotti and 
Johnson, 1978). Demonstration of a correlation coefficient 
of + 0»88 for inhibition of NTE in brain and in lymphocytes 
opens the possibility of using the test in man (Dudek et al., 
1979). 
So far, the NTE test has two limiations. First, results 
of the test do not explain the delay inherent in classical 
neurotoxicity (Johnson, 1969a). Second, the test usually 
is carried out on homogenates of brain,' a tissue that shows 
little if any functional or morphological change in 
polyneurophathy. 
Hence, most of the organophosphorus compounds that 
produce neurotoxicity of any sort produce either the delayed 
irreversible or the immediate reversible form leading to a 
2 :.'\ 
great spectrum of effects and in spite of some progress, there 
is still much mystery about why some compounds of phosphorus 
are neurotoxic and other are not. 
1.8.0 Reports Available on the Poisoning due to Orqanophosphate 
Insecticides 
The incidence of poisoning has been reported from various 
parts of the world. Statistical surveys of mortality and 
morbidity resulting from acute exposures to insecticides reveal 
that children are the victims of a high percentage of accidental 
fetal poisonings. The greatest incidence has been reported from 
Japan (population 98.9 million), where there were 19,436 cases 
of organophosphate insecticide poisoning during seventeen years, 
including 10,^ 031 accidental and 9,^ 405 suicidal or horaocidal 
cases, with 9,'460 deaths by the Ministry of Health and Welfare 
(Japanese Government, 1954-1970). In Finland (population, 4.7 
million) there were 286 deaths during six years, including 237 
suicide, forty two accidents and seven homicides (Toivonen et al., 
1959). In Denmark 273 deaths occurred during six years including 
263 suicides, six accidents and four homicides (Frost and 
Paulsen, 1964). In California, there were 950 cases of poisoning 
during four years, including 789 agricultural, ninety one 
industrial and seventy other causes (Department of Public 
Health, State of California, 1957-1960). In Dade country, 
Florida, sixty five deaths were recorded during 12 years. 
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including twenty seven suicides, twenty four accidents, 
eleven homicides and three occupational poisoning (Reich 
et al., 1968). Incidents of mass poisoning by gross contamina-
tion of food with orycinophospnates has been reported from 
India, Egypt, Singapur and Mexico. An "epidemic" of poisoning 
due to malathion, an organophosphate that is generally considered 
safe, occurred among field workers in a malaria control program 
in Pakistan (Baker et al., 1978). Out of the 75,000 workers 
involved in this mosquito control program 2,800 were estimated 
to have had at least one episode of malathion intoxication. 
Five of these were fatal cases. In United States the incidence 
of poisoning by organophosphate insecticides has been lower 
than the incidence of poisoning by some other pesticides such 
as arsenicals and cyanide compounds (Hayes, 1959). Somehow, 
approximately 20,000 Americans were paralysed in 1930 when 
ginger got adulterated with lindol (Aring et al., 1941; 
Aring, 1942). Eleven cases of paralysis were observed in 
Holland (Moeschlin, 1952) and sixty in Germany (Creutzfeldt 
and Orzechwak, 1941-1943). Another outbreak of paralysis 
occurred in Durban (1957) when eleven Africans used water 
stored in drums taken from a paints factory. Many other cases 
of paralysis have been reported from different countries 
including England, Germany and India (Vora et al.,' 1962). 
According to a report from California, out of the 175 
cases of systemic poisoning, organophosphate insecticides 
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were responsible for 80 percent, and they were involved in 
47 percent of another 160 reports of digestive and other 
non localized symptoms of illness. This high contribution 
of systemic poisonings due to organophosphates continued the 
record of several years (from 1956 to 1969 from 125 to 407 
reports of systemic occupational poisonings were reported 
annually in California). 
Furthermore, there have been repeated cases of multiple 
poisoning among agricultural workers engaged in picking fruits 
sprayed with the highly toxic organophosphate insecticides 
parathion (Spear et al., 1975). Sachitanand (1983) is of the 
view that pesticides threaten the welfare of the poor in the 
Third World Countries, because of their free availability, 
lack of adequate protection, improper storage, excessive and 
wasteful use leading to environmental pollution-
1.9.0 Complexity of Environmental Problems 
Increasing use of pest control chemicals has generated 
serious problems of environmental pollution. It is apparent 
that there are many sources of exposure of humans and other 
nontarget species to pesticides by direct contact with 
materials at the site of application. In recent years, however, 
it has become increasingly apparent that exposures to pesticides 
far remote from the source of application are also possible. 
This results from the translocation of the chemical from 
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their sites of application through the various media of the 
environment. The extent to which translocation within the 
environment occurs will depend to a large degree on the 
physicochemical properties of the pesticides. Perhaps one 
of the most important factors is the extent of and time 
required for degradation of chemicals to simpler non-toxic 
forms. 
Other nonbiologic modes of translocation include vapori-
zation and drift by air borne routes so that materials are 
carried by prevailing wind patterns far remote from their site 
of application. Subsequently they may be precipitated out by 
rainfall onto land surface waters in areas in which the pesti-
cides have not been applied directly. Application to the soil 
may result,' ultimately, in suspension of the pesticides, 
absorbed on soil particles, and air borne translocation as 
dust. The extent to which pesticides will remain in soil after 
application depends upon a number of factors:such as soil type, 
moisture, temperature, pH, micro-organism content, degradability 
of the pesticide itself, and the extent of cultivation and 
cover crops (Lichtenstein, 1966). Interestingly the chemical 
changes of the parent insecticides that result from either 
physicochemical reactions in the environment or biologically 
catalyzed reactions may lead to products with either greater 
or lesser potential for biotransformation. However, the 
build up of residues of non-biodegradable pesticides in human 
EXPLANATION OF THE FIGURE 
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and animal tissues has caused the greatest concern from health 
point of view(Newraan, 1965 and Upchurch, 1974) {Fig. 4 ). 
1•10.0 Sign and Symptoms of Toxicity of Orqanophosphorus Compounds 
The usual symptoms of organophosphate poisoning 
include:headache, giddiness, nervousness, blurred vision, 
weakness, nausea, cramps, diarrhoea and discomfort in chest etc. 
Signs and symptoms of acute poisoning by organophos-
phate insecticides are predictable from their biochemical 
mechanism of action. Thus the inhibition of acetylcholinesterase 
by organophosphates results in accumulation of endogenous acetyl-
choline in nerve tissues and effector organs with consequent 
signs and symptoms that mimic the muscarinic, nicotinic, and 
central nervous system actions of acetylcholine. 
Muscarinic receptors for acetylcholine are found 
primarily in smooth muscles, the heart, and exocrine gland. 
Signs and symptoms of organophosphorus insecticide poisoning 
that result from stimulation of these receptors include tightness 
in the chest and wheezing expiration due to bronchoconstriction 
and increased gastrointestinal tone etc. 
Nicotinic actions at the neuromuscular junctions 
of skeletal muscle usually consist in scattered fasciculations, 
muscular twitching, cramp weakness, fatiguability and paralysis. 
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TABLE-5 : Sign and Symptoms of Organophosphate Poisoning 
MUSCARINIC MANIFESTATIONS; 
Bronchial tree 
GASTROINTESTINAL SYSTEM; 
Sweat Glands 
Salivary Glands 
Lacrimal Glands 
Cardiovascular System 
Pupils 
Ciliary body 
Bladder 
NICOTINIC MANIFESTATIONS; 
Striated Muscle 
Sympathetic Ganglia 
CENTRAL NERVOUS SYSTEM-
MANIFESTATIONS; 
Tightness in chest, bronchocons-
triction, dyspnea increased 
bronchial secretion, cough, 
pulmonary edema, cyanosis. 
Nausea, vomiting, abdominal 
tightness, diarrhea, fecal 
incontinence. 
Increased Sweating 
Increased Salivation 
Increased Lacriraation 
Bradycardia, fall in blood pressure 
Miosis occasionally unequal 
Blurring of vision 
Frequency, urinary incontinence. 
Fasciculation, muscular twitching, 
cramp, weakness in respiratory 
muscle. 
Giddiness, tension, anxiety, 
restlessness, emotional lability, 
excessive dreeming, insomnia, 
headache, apathy, drowsiness, 
coma, convulsions, depression of 
respiratory and circulatory centres 
and fall in blood pressure. 
Modified by Grob and Harvey (1953). 
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The most serious consequence of neuromuscular action is paralysis 
of the respiratory muscles. 
Accumulation of acetylcholine in the central nervous system 
is believed to be responsible for the broad spectrum of effects 
such as, giddiness, tension, anxiety, restlessness, emotional 
lability, excessive dreaming, insomnia, headache, etc Depression 
of respiratory and circulatory centres and fall in blood pressure 
are other CNS effects (Table 5 ). Effects may be localized or 
systemic (Table 6 and 7 )• 
TABLE - 6 : Signs and Symptoms of Organophosphate Poisoning 
Following Local Exposure 
Site of action Signs and symptoms 
Pupils 
Ciliary body 
Conjunctivae 
Nasal mucous membrane 
Bronchial tree 
Sweat glands 
Striated muscle 
Miosis, marked, usually maximal 
(pin-point), some times unequal. 
Frontal headache, eye pain on 
focusing, slight dimness of vision, 
occasional nausea and vomiting. 
Hyperaemia 
Rhinorrhoea, hyperaemia 
Tightness in chest, some times with 
prolonged wheezing expiration 
suggestive of bronchoconstriction 
or increased secretion, cough. 
Sweating at site of exposure to 
the liquid. 
Fasciculations at site of exposure 
to the liquid. 
TABLE 7 : Signs and Symptoms of Organophosphate Poisoning 
Following Systemic Absorption 
Site of action Signs and symptoms 
Pupils 
Ciliary body 
Bronchial tree 
Gastro-intestinal 
system 
Sweat glands 
Salivary glands 
Lachrymal glands 
Heart 
Bladder 
Striated muscle 
Sympathetic ganglia 
Central nervous 
system 
Slight moisis (occasionally unequal), 
later more marked. 
Burning of vision. 
Tightness in chest, with prolonged 
wheezing expiration suggestive of bron-
choconstriction or increased secretion, 
dyspnoea, slight pain in chest, increased 
bronchial secretion, cough. 
Anorexia, nausea, vomiting, abdominal 
cramps, epigastric and substernal tightness 
with "heartburn" and eructation, diarrhoea, 
tenesmus, involuntary defecation. 
Increased sweating. 
Increased salivation. 
Increased lachryraation. 
Slight bradycardia. 
Frequent or involuntary micturition* 
Easy fatigue, mild weakness, muscular 
twitching, fasciculations, cramps, gene-
ralized weakness including muscles of 
respiration, with dyspnoea and cyanosis. 
Pallor, occasional elevation of blood 
pressure. 
Giddiness; tension; anxiety; jitteriness; 
restlessness; emotional lability; excessive 
dreaming; insomina; nightmares; headache; 
tremor; apathy; withdrawal and depression; 
bursts of slow wares of elevated voltage 
in EEG especially on overventilation; 
drowsiness; difficulty in concentrating; 
slowness of recall; confusion; slurred 
speech; ataxia; coma with absence of reflexes 
cheynestokes respiration; convulsion; depre-
ssion of respiratory and circulatory centres 
with dyspnoea; cyanosis and fall in blood 
pressure. 
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1.11.0 Diagnosis and Treatment of Poisoning; 
1.11.1 Diagnosis: Diagnosis is of three kinds:diagnosis of 
incipient cases, showing no overt symptoms, diagnosis 
in casualties, and diagnosis of post-mortem. 
Diagnosis of incipient cases is carried out by 
estimating the AChE activity of blood samples or the 
QiE activity of plasma samples. Such tests are carried 
out routinely on many engaged in spraying or manufac-
turing phosphorus insecticides. They show whether a 
worker has absorbed a phosphorus compound or not, and 
consequently whether he is likely to be unusually 
sensitive to a further dose. ChE is lowered faster 
than AChE by most phosphorus poisons, and there are 
no cases reported in which it is not lowered as fast 
initially, but ChE may recover faster than AChE, so 
that the ChE level may led to an underestimate the 
residual effects of a dose received some time earlier. 
Therefore, ChE determinations are a reliable and 
sensitive method of diagnosing its early stages. 
Diagnosis in casualties depends mainly upon 
recognizing the very general nervous symptoms. It may 
be confirmed by giving about 2 mg of atropine. In normal 
subjects this causes marked atropinization, but in a 
case of phosphorus poisoning relieves the symptoms, 
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without atropinlzing (Golz, 1959). Estimations of ChE are 
confirmatory. 
Diagnosis at autopsy may be of financial importance to 
dependants of the deceased. There are no gross pathological 
changes and diagnosis depends mainly upon determinations of 
AChE either in erythrocytes or histochemically at myoneural 
junctions (Petty, 1958). 
1»11«2 Treatment of Poisoning in Man; Organophosphates if in 
sufficient doeses may have a rapid fatal outcome. It 
is important therefore, to take emergency action in-
cluding, removal of the toxic agent and decontamination 
of exposed skin with an alkaline solution of soap and 
water, even though complete history may not have been 
obtained. 
In very serious cases of poisoning by organic 
phosphorus insecticides, the order of treatment should 
be as follows:-
(1) artificial respiration, preferably by mechanical 
means; 
(2) atropine sulfate (2 to 4 mg) intravenously and 
repeated at 5 to 10 minute intervals until signs 
of atropinization appear; 
(3) paralidoxime chloride (Igm) slowly, intravenously; 
3S 
(4) decontamination of the skin, stomach, and eyes 
and 
(5) symptomatic treatment (e.g. inhalation of oxygen). 
In usual cases, the procedure should be as follows:-
(1) atropine sulphate (1 to 2 mg) if symptoms appear, 
and repeated doses as required by excessive 
secretions, (2) decontamination of the skin, stomach 
and eyes; (3) paralidoxime chloride (igm) slov/ly 
intravenously if the patient fails to respond 
satisfactorily to atropine; and (4) symptomatic 
treatment, 
1«11«3 Treatment of Poisoning in Animals: Atropine, enzyme 
reactivators and symptomatic care, constitute the most 
important means of treating poisoning by organic 
phosphorus compounds in man. Their value is so firmly 
established by pharmacological theory and clinical 
experience that there is no need to review studies in 
animals that first explored and later confirmed their 
value. It is desirable to review animal experiments 
exploring certain other compounds that may be useful 
for treating poisoning by organic phosphorus compounds. 
Glucose: Glucose apparently gave some protection when 
3 ml of a 20% aqueous solution were injected intra-
peritoneally in rats poisoned by parathion, parathion-
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methyl, and demeton (Diechmann and Rakoczy, 1953). 
Glycogen stores may be depleted during poisoning, 
but this is more likely to be signficant in small 
animals• 
Cysteine; It was reported that cysteine protected 
animals intoxicated by parathion (Botescu et al., 1970) 
but the pharmacological basis is not clear, and the 
finding apparently has not been reinvestigated. 
Vitamin C; According to Karimov (1974), there is a 
significant reduction in the concentration of vitamin 
C in the blood and urine of people considered to have 
squelae of acute poisoning. The same was true of 
rabbits receiving 3.8 mg/kg/day of dimethoate plus 
3.1 mg/kg/day of lindane for 3 months. Vitamin C 
at the rate of 30 mg/kg/day restored the normal blood 
level of this vitamin, reduced the abnormally high 
blood alkaline phosphatase level, and was considered 
to improve the detoxifying power of the liver. It was 
recommended that vitamin C, unlike vitamin B, should 
be used in treating chronic poisoning by pesticides. 
Reduced Glutathione (GSH); In pigs, plasma choline-
sterase activity that had been depressed by parathion-
methyl was increased temporarily by GSH (Matsueda et al. 
1972b). The reported results do not yet justify use 
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of multiple doses of GSH in human therc^ py, but further 
studies should focus on influences of GSH on the rate 
of metabolism of different organic phosphorus compounds 
and on the survival of poisoned animals. 
1»12«0 Metasvstox- an Orqanophosphate 
Metasystox-R, {0,0-dimethyl-S-2(ethylsulphinyl) 
ethylthiophosphate) sometimes called Oxydemeton methyl or 
methylisosystox sulfoxide, is a systemic organophosphate 
insecticide exhibiting marked specificity in its action against 
spider, mites, aphids leafhoppers and similar plant sucking 
insects. It features good plant tolerance. Beneficial insects, 
such as larvae of Coccinellidae and Syrphidae, remain very 
largely unharmed by application of metasystox. It is also 
unique because of its total water solubility as well as being 
soluble in most organic solvents. 
1.13.0 Synonyms 
Metasystox is the trade name for Oxydemeton-methyl. 
The compound can be accurately described as demeton-S-methyl 
sulfoxide by reference to the ISO-approved name of the parent 
compound, and this term is sometimes used as a name. However, 
in Germany, a different convention has been used by which 
reference is made to 0, and thus the term, demeton-O-methyl 
sulfoxide to the compound. However, the term demeton-S-methyl-
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sulfoxide also is used in Germany. Ossidemeton-metile is the 
term used in Italy, and metilmekaptophrosoksis is used in USSR. 
Other common names include isomethylsystox-sulfide and meta-
isosystox sulfoxide. Code designations for metasystox have 
included Bayer-21097, ENT-24964, and R-2107, the CAS registry 
number is 301-12-2. 
1.14.0 Chemical and Physical Properties 
Metasystox has the following physico-chemical 
properties: 
Chemical name: 0,0-dimethyl-S-2 (ethylsulphinyl)ethylthiophosphate 
Common name : Demeton-0-methylsulphoxide (Germany) 
Oxydemeton-methyl (England) 
Structural formula: 
0 
U 
CH^O 0 \M 
^ P - S - CH„ - CH^ - S - C„H. y 2 2 2 5 
«3° 
Empirical formula: CgHn^O^PS-
Appearance and odour 
Molecular weight 
Boiling point 
Volatility 
Yellowing liquid, practically odourless 
246.3 
106°C at 0.01 mm.Hg. 
0.09 mg/m^ at 20°C 
0.3 mg/m"^  at 30°C 
0.7 mg/m^ at 40°C 
39 
Specific gravity 
Refractive index 
1.289 at ^  C 
40° 
n 
20 
= 1.5216 
Solubility 
Stability 
: Miscible with water in any ratio. 
Soluble in most organic solvents, but 
practically insoluble in petroleum 
ether. 
: In aqueous solution, the active 
ingredient slowly hydrolysis. 
It is not stable in alkaline media-
1.14.1 Formulations 
R Metasystox is available as a 50% solution concentrate 
and a 25% emulsifiable concentrate. Formulation retains 
full biological activity for at least 2 years when 
stored at 20 to 30°C. 
1.15.0 Metabolism of Metasystox 
The metabolism of metasystox (demeton-raethyl) in 
plants and animals WaS stuaieo by Fukuto et. a'l. (1955). 
Similar studies with methyl analog of PO-demeton, were carried 
out by Muhlmann and Tietz (1956). These investigators showed 
that metasystox, like PO-demeton, is converted to the corres-
ponding sulfoxide and sulfone- It seemed likely that the action 
of metasystox would be due mainly to the sulfoxide and sulfone 
of the 0,0--diraethyl-S-ethyl thioethyl phosphoratothiolate 
produced metabolically both in plants and animals. In addition 
to isomerizing, it reacts with itself to form sulfonium ions 
of greatly increased toxicity and anticholinesterase activity 
as shown in Fig.5 
(CHjO)^  P + I s - C^ Hg 
(CHgO)^ P C2H5 
\ CH2CH2 S - CH2CH2SC2H5 (1) 
(Unstable inhibitor) 
,0 
(0130)2 P f > (CH30)2P^ ^ 0-13 
^S CH2CH2SC2H^ SCH2CH2S - 0^^ 
(methylsulfoniothillate) 
P^ 
"0 ^S CH2CH2S C2H5 .... (2) 
Fig. 5 : Schematic representation of metabolic pathways 
of metasystox. 
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1.16.0 Toxicity of Metasystox 
1.16.1 Toxicity to Animals: Metasystox (Oxydemeton-methyl) is 
a compound of moderate actue toxicity, as shown in 
Tablet 8 ). Rats given dietary levels of 200 and 
100 ppm (about 10 and 5 mg/kg/day) not only showed 
marked inhibition of cholinesterase activity but also 
signs of intoxication during the first 3 weeks (Vandekar, 
1958). In anoxner study, no illness or pathology was 
produced by 5 mg/kg for 3 months (Wirth, 1958)f A 
dietary level of 50 ppm also inhibited cholinesterase 
but produced no signs of illness and did not interfere 
with growth (Vandakar, 1958). 
1.16.2 Toxicity to Man: Some cases of poisoning by metasystox 
involved relapse in the course of a long illness • In 
one instance, a 17 year old girl was found unconscious 
with an empty bottle beside her. She was in a coma, 
and had nearly all the signs of anticholinesterase 
poisoning except pulmonary edema. She was hospitalized 
12 to 15 hours after the estimated time of ingestion. 
She received first aid treatment, including gastric 
lavage, assisted respiration, atropine and 2 PM. Her 
condition began to deteriorate on the second.day. In 
spite of vigorous treatment, there was no more change. 
A blood transfusion was performed on the 10th day. The 
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TABLE - 8 
Single Dose LD5Q for Metasystox (Oxydemeton-methyl) 
Species Route (rag/Kg) Reference 
m 
m 
m 
m 
m 
r a t , 
^^t , 
r a t , 
r a t , 
r a t , 
r a t , 
r a t , 
r a t , 
r a t , f 
r a t , 
r a t , 
mouse 
mouse, ra 
mouse, f 
g pig 
g pig 
rabbit 
oral 
oral 
oral 
oral 
oral 
oral 
derm 
derm 
derm 
ip 
iv 
oral 
ip 
ip 
oral 
ip 
oral 
65 Heath and Vandekar, 
1957. 
65 DuBois and Plzak, 
1962 
75 DuBois and Plzak, 1962. 
30-75 Schrader, 1963. 
47 Gaines, 1969. 
52 Gaines, 1969. 
250 DuBois and Plzak, 1962. 
173 Gaines, 1969. 
158 Gaines, 1969. 
20 DuBois and Plzak, 1962. 
47 Heath and Vandekar, 
1957. 
30 DuBois and Plzak, 1962. 
12 DuBois and Plzak, 1962. 
8 DuBois and Plzak, 1962. 
120 DuBois and Plzak, 1962. 
30 DuBois and Plzak, 1962. 
104 Khaitov et al., 1971. 
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patient was released after 41 days with all clinical and 
laboratory findings normal (Goebel et al«, 1969). 
Another poisoning {involving relapse) was the results 
of injection of a mixture of 20^ metasystox and 17.5% 
parathion with suicidal intent (Knolle, 1970). 
A third example involved a suicide attempt by a 
40 year old woman. She received gastric lavage 2 hours 
after ingestion and was hospitalized 4.5 hours after 
ingestion. Approximate treatment with drugs had led 
to a regression of miosis, however, the patients suffered 
cardiac arrest at 48 hours and again at 72 hours after 
admission. Heart action was restored each time by 
external cardiac massage. Clinical recovery was essen-
tially complete by the 8th day. Plasma cholinesterase 
had returned to normal by the 13th day (Gaultier et al., 
1975). 
1»1'7»0 Treatment of Metasystox Poisoning 
The efficacy of atronine and pyridine-2--aldoxime 
methiodide (2-PAM) given separately and in combination was 
investigated in rats acutely poisoned by metasystox (DuBois 
and Plazak, 1962). The influence of l,l-trimethylenebis--4-
formylpyridinium bromide(TMB-4)on acute poisoning by this 
organic phosphate was also tested by DuBois and Plzak (1962). 
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TABLE-9 : Protective Effect of Atropine Sulfate, 2-PAM, and 
TMB-4 Against the Acute Toxicity of Metasystox to 
Rats (DuBois and Plzak, 1962) 
Antidote 
Dose of Number Approx. LD^Q of 
antidote of Rats Metasystox 
(mg/kg) (mg/kg) 
None 
Atropine s u l f a t e 
2-PM1 
TMB-4 
Atropine s u l f a t e 
p lus 2-PAM 
100 
100 
75 
100 
100 
40 
25 
25 
24 
26 
21 
50 
60 
70 
80 
These experiments demonstrated that the combination of atropine 
sulfate with 2-PAM provided mere protection than either agent 
alone as evidenced by a four-fold increase in the LD^Q °'^  
metasystox. The results of these measurements are summarized 
in Table-9 (DuBois and Plzak,. 1962). 
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1.18.0 Brain Lipids 
Lipids are biological materials containing a mixture 
of compounds of widely differing chemical composition. The 
brain is rich in lipids, which constitute structural elements 
of the plasma membrane, components of ion channels, comprise 
portions of neurotransmitter receptors, and are major consti-
tuent of myelin. The range of values for myelin total lipid 
is 60-3CP/O of dry weight (White et al. 1978). The important 
lipids of the central nervous system are cholesterol, cerebro-
cides and phospholipins, lecithin, sphingomyelin and kephalin 
(Johnson, Mc Nab and Rossiter, 1948). 
Waelsch, Sperry and Stoyanoff (I94l) have studied 
that after birth lipid is deposited in the brain as a result 
of two processes, (a) growth and (b) myelination. Immediately 
after birth and before myelination is complete there is an 
active deposition of brain lipids (Fries, Changus and 
Chaikoff, 1940). The lipid class distribution among animals 
of the same species is highly variable. Thus, brains of rats 
and mice frequently have less cerebroside, sulfatide and corres-
pondingly more phosphatidylcholine and phosphatidyl ethanolamine 
than human brain, but some rodent brains have the same high 
sphingolipid levels found in human brain. The data of Galli 
et al. (1970) indicate that rat brain may have sphingomyelin 
levels as high as in human brain. 
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Surrounding nerve axons and dendrites in the peripheral 
nervous system, the cell bodies of sensory ganglion cells and 
the nerves of the white matter of the central nervous system 
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is a sheath of myelin formed by the neurilemmal or Schwann 
cells. The complete lipid analysis of myelin from different 
species has been published by various workers (Autilio et al., 
1964; Eichberg et al., 1964; O'Brien, 1965), The 
protein content is characteristically low, about 22% for light 
myelin and 26-29% for heavy myelin (Autilio et al., 1964; 
Fong,1966b) and conversely the lipid content, about 78% 
(Autilio et al., 1964) is higher than any other brain sub-
cellular fraction. Early analysis of white matter revealed 
that cholestrol sphingomyelin, and cerebroside were present in 
larger amounts than in the grey matter (Johnson et al., 1948). 
Furthermore, a comparison of the lipids in the newborn and 
the adult brain showed little change in the grey matter with 
maturation, but increasing amounts of free cholesterol, cere-
broside, and sphingomyelin in the white matter as a function 
of age (Johnson et al., 1949a). Cumings (1953, 1955) compared 
the lipids of demyelinated lesions in multiple sclerosis with 
those of normal areas of the brain and found a decrease in 
sphingomyelin, cerebroside, and free cholesterol. Similar 
findings were made in demyelination resulting from Wailarian 
degeneration of the peripheral nerve (Rossiter, 1961; Berry 
et al., 1965). 
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The available literature on total lipids indicate that 
the knowledge of organophosphate toxicity on brain lipids is 
inadequate. Since the brain regions show remarkable hetero-
geniety in lipid levels, it is reasonable to investigate the 
neurotoxicants influence on different regions of the brain. 
The present study deals with the effect of metasystox on lipid 
concentration in different regions of the rat brain. 
1«19.0 Phospholipids in the Brain 
Phospholipids are the primary lipid components of 
plasma membranes, organic membranes and are important in myelin 
membranes as well. The importance of phosphorus containing 
lipids of the central nervous system, presumably dependent upon 
their role as membrane constituents. The analytical figures 
show that the phospholipid composition of myelin isolated from 
peripheral nerve is very similar to that of brain myeling 
(Table 10) but there is a significant increase in the phospho-
lipid :cholesterol ratio as compared with myelin from the brain 
of the same animal. Certain phospholipids were found to be 
more concentrated in the white than in grey matter, and since 
their accretion parallels myelination, it was proposed that 
these lipids were characteristic components of the myelin 
sheath (Fumagalli and Pao Letti, 1963). The metabolically 
active polyphosphoinositides are located in the excitable 
4 a?! 
membrane of the neurone, particularly the exolemma• This 
distribution in brain of the enzymes responsible for the 
biosynthesis of the compounds and the influence of cations 
(e.g. Ca ) on the enzymes suggests that the phosphorylation 
and dephosphorylation is at least partially responsible for 
the regulation of axonal membrane permeability to Na and K 
ions. 
TABLE- 10 : Phospholipid Ratios for Myelin from the Central 
and Peripheral Nerve System 
Rat myelin Guinea pig myelin 
CNS PNS CNS PNS 
Choline phosphatides 
Ethanolamine 
phosphatides 
Serine and inositol 
phosphatides 
24 
48 
10 
24 
37 
19 
25 
42 
20 
21 
45 
28 39 34 34 
Sphingomyelin 18 20 13 
Results expressed as percentages of total phospholipid. 
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Phosphoitidyl glycerol is only a minor component of 
cerebral lipids. Stanacev et al. (1968) and Possmayer 
et al. (1968) established that the compound is biosynthesized 
in brain by the following reactions. 
1. CPD - diacylglycerol + Sn - glycero - 3- phosphoric acid —y" 
3 - Sn - phosphatidyl - 1 - glycerol - 3' phosphate + CMP 
2. 3 - Sn - phosphatidyl - 1' - glycero - 3' - phosphate -7 
phosphatidylglycerol + P[_ 
The incorporation of radioactive phosphorus in the 
phospholipin fraction and of deuterium in both the fatty acid 
and non-soaponifiable fraction of the brain lipids (Waelsch 
et al., 1941) was greatest in young rats immediately after 
birth when growth was greatest, and decreased sharply with 
increasing age, even although myelination was proceeding 
rapidly (Johnson, 1949). 
Lunt et al. (l97l) reviewed the effect of acetylcholine 
on phosphotidylionositol phospholipids. Nelson and Barnum(l960) 
have demonstrated the effect of anticholinesterase, DFP on 
brain phosphotidyl-choline mdtabolism. Neurochemical studies 
of regional phospholipid changes of rat brain following the 
administration of metasystox have not been reported in the 
literature and present investigation provides information on 
the effects of organophosphate metasystox on brain phospholipids. 
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1.20.0 Cholesterol in the Brain 
Although cholestrol is widely distributed in various 
body tissues, it is found in highest concentration within the 
central and peripheral nervous systems. It accounts for about 
lO^ o of dry weight of the brain in contrast to less than 1% 
found in most other organs. This high concentration of cholesterol 
seems to be characteristic of nervous tissue. The constancy of 
amount of cholesterol in the brain suggests that the sterol is 
metabolically stable (Waelsch et al. 1940). Laatsch et al. 
(1962) demonstrated that cholesterol accounts for l8-'2CP/o of the 
dry weight of the myelin fraction and that about 70% of the 
total brain cholesterol is present in the myelin. Fetal or 
neonatal brain prior to myelination contains relatively little 
cholesterol. Kritchevsky and Holmes (1962) found varying 
amounts of the sterol in the newborn rat brain. Recently 
Fumagalli and Paoletti (1963) and Fumagalli et al. (1964) 
reported that desmosterol accounted for upto 7% of the human 
and rat fetal and neonatal brain sterol content. Desmosterol 
is rapidly converted into cholesterol in the brain where it 
seems probable that it is an important precursor of brain 
cholesterol (Fish et al., 1962). 
Johnson et al. (1949) found more than 4% of cholesterol 
as ester in infant while matter, white less than 2% was found 
in infant grey and adult grey and white matter. Pritchard 
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(1963) has detected small amounts of cholesterol ester in the 
brain lipids of the 7-day-old rat. More specific localization 
of cholesterol by histochemical means (Adams, 1961) indicate 
a strong reaction in the myelin sheath of peripheral nerve and 
in fiber tracts of the brain. A large portion of adult rat, 
rabbit, or chicken brain cholesterol undergoes very slow 
metabolism. Metabolism of cholesterol in the brain was different 
from that in other tissues (Waelsch et al., 1940). It seemed 
probable from their experiments that the cholesterol was largely 
synthesized within the developing brain while suitable precursors, 
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such as 1-C acetate are readily utilized by young animals. 
There is a progressive decrease during development in the amount 
incorporated into central nervous system but not into liver 
cholesterol (Nicholas and Thomas, 1959a,b). Since about 70% 
of brain cholesterol is located in the myelin sheath, it is 
probable that at least part of this structure is metabolically 
a relatively stable tissue component. No information is available 
thus far on the cholesterol levels in the rat brain following the 
administration of organophosphate metasystox. 
1»21»0 Fatty Acids of the Brain 
The type of fatty acid and percentage composition of the 
fatty acid content of most brain lipids has been compiled by 
Eichber et al. (1969). Free fatty acids are present only in 
small amount in central nervous tissue, in combination, mainly 
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as long-chain fatty acids they constitute a large portion of 
the major lipids of the brain and spinal cord. 
Fatty acid metabolism in the central nervous system has 
been studied by D'Adamo (i960). The combined yield of free 
fatty acids from subcellular fractions of rat brain was greater 
than that from fresh tissue. Fatty acids in the central nervous 
system can arise by synthesis in situ and by transport from the 
blood stream (D'Amado, 1970). Recent studies have again indi-
cated that both possibilities exist (Dhopeshwarker and Mead, 
1970). The enzymes of the fatty acid oxidizing system are 
p-hydroxyacyldehydrogenase and ^ -ketoazyl thiolase (Lynen, 1954). 
An additional enzyme required for long-chain fatty acid degrada-
tion, fatty acyl-CoA synthetase {Acid:CoA ligase (AMP), EC 6.2.1.3), 
has been studied by Pande and Mead (1968). On a specific activity 
basis, liver was most active testes and serum least active, and 
brain somewhere in between. The amount of the fatty acid compo-
sition of each lipid class of human brain changes continuously 
throughout the life (Rouser et al., 1968 and Rouser et al., 1968). 
Hansen and Clasusen (1968) investigated the fatty acids of 
the human fetal brain. The predominant acids were palmitic, 
stearic, and oleic in brain as a whole, and in fetal brain, 
lecithin, phosphaticylethanotamine, and phosphatidylserine. In 
adult brain oleic was dominant in all of these phospholipid 
fractions. Lionoleic acid was practically absent in all of these 
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phospholipid fractions. Linoleic acid was practically absent in 
fetal brain but represented 4.5% of the total fatty acids present 
in adult brain. 
Following post-decapitation ischemia and after electro-
convulsive shock in rats, Bazam (1970) found that a striking 
rise in the total free acid pool in brain occurred. Several 
reports (e.g. Witting and Horwitt, 1967), indicated changes in 
the fatty acid content of various tissues in Vitamin E deficiency. 
At present, no attempt has been made to evaluate the effect of 
pesticide metasystox in the various regions of the rat brain and 
spinal cord. Therefore, it would be of interest to estimate the 
levels of fatty acids quantitatively after the administration of 
three graded doses of metasystox. 
1.22.0 Ganqliosides in the Brain 
Ganglioside is the generic term for glycosphingolipids 
containing sialic acid, which are a group of derivatives of 
neuraminic acid. Gangliosides are thought to be primarily 
responsible for specific cellular reactions. It is now generally 
assumed that exogenous ligands such as bacterial toxins, antigens, 
calcium ion and so on, bind to specific gangliosides to induce 
sequential activations of membrane-associated enzymic reactions 
and cellular metabolism (Fishman and Brady, 1976a; Yamakawa and 
Nagai, 1978; Hakomori, 1981). 
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Gangliosides are ubiquitously distributed in neural 
tissues of vertebrates only, and the composition and content 
seem to vary among different brain regions. The reported 
data on the localization of gangliosides have been summarized 
by Ledeen and Yu (1976). Gray matter contains much more lipid-
bound sialic acid than white matter and other myelin rich 
tissues such as spinal cord peripheral nerve. It is probably 
safe to say that astroglia and neuronal perikarya show similar 
patterns of gangliosides (Abe and Norton, 1974). On the other 
hand myelin has a characteristic pattern with GM^ and (M^ as the 
major ganglioside species (Ledeen et al., 1973; Yu and Iqbal, 
1979). The ganglioside pattern of oligodendroglia resembles 
that of white matter and to some extent that of neuronal perikarya, 
but oligodendroglia are quite different from neuronal perikarya 
and astroglia in containing much more GM.. GM. therefore, is 
considered to be specifically localized in human myelin and 
oligodendroglia, suggesting that GM> as well as GM, are synthesized 
in oligodendrocytes and preferentially incorporated into the 
myelin sheath in myelinogenesis (Yu and Iqbal, 1979). The myelin 
is also characterized by an unusually high level of GJVL, which 
accounts for more than 30% of the total gangliosides. 
Gangliosides are principally synthesized in neuronal 
perikarya and transported to nerve endings together with 
macromolecules (Rehmann and Rosner, 1973; Ledden et al., 1976b; 
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Landa et al., 1979), but local synthesis within the axon and 
nerve endings (Ledeen et al., 1976b; Tettamanti et al., 1980) 
or even at the plasma membrane level (Preti et al., 1980) can 
not be excluded. Synaptic membranes are thus supposed to 
incorporate as a unit most of the gangliosides transported 
from neuronal cell bodies by axdnal flow. 
Gangliosides seemed to be gradually degraded in tissues, 
and only 20-3C^ of the original activities were lost within 
8 days. Two-thirds of the metabolites were removed through 
the kidney, and one-third through the liver. Lysosomes are 
thought to be a major locus for the degradation of gangliosides 
(Sandhoff and Christomanou, 1979). 
Ganglioside changes related to development have been 
extensively studied in the nervous system. The total genglio-
side level in rat brain increased rapidly daring the period just 
before myelinogenesis, 7-16 days after birth and the level 
remains constant thereafter throughout the adult period 
(Susuki, 1965; Rehmann, 1980). Postnatal pattern changes of 
human brain gangliosides were also reported by Susuki (1965). 
Yamakawa and Nagai (1978) discussed the possible role of ganglio-
sides as receptors and modulators of membranes machinery and 
also mentioned the therapeutic trials with gangliosides in 
relation to the activating effects of gangliosides on neurite-
genesis. To my knowledge, the effect of organophosphate 
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pesticides on gangliosides are limited and particularly, the 
effect of organophosphate-metasystox on ganglioside is not known, 
therefore, it would be of particular interest to evaluate the 
ganglioside levels in different regions of the rat brain after 
the administration of three doses of organophosphate-metasystox. 
1.23.G Lipid Peroxidation 
Lipid peroxidation has been associated in various ways with 
a number of normal and abnormal physiological processes. Recent 
interest in lipid peroxidation has probably resulted from the 
realisation that oxygen radicals and other organic radicals do 
indeed exist in biological tissues for an appreciable time- The 
peroxidation of endogenous phospholipids in biological membranes 
has long been thought to be the basis for a variety of toxicolo-
gical phenomena. 
Lipid peroxidation appears to be a phenomenon that reflects 
free radical events associated with biological membranes, which 
contain most of the polyunsaturated fatty acid containing lipids 
in animal tissues. In addition, biological membranes are filled 
with active catalists of oxidation of fatty acids by oxygen with 
peroxide formation (lipo-peroxidation) such as hemoproteins and 
nonheme iron, copper, and manganese complexes- The consequences 
of oxidation of even a small portion of unsaturated fatty acids 
in the phospholipid bilayer are obviously dramatic:deterioration 
of barrier and matrix function of the lipid bilayer, enzyme 
inactivation, toxic effects on cell division, etc. Apparently 
the formation of membranes in primary cells proceeded in 
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reduced atmosphere, and later the cells developed specialized 
systems to protect their membrane substance against oxidation 
by free oxygen. 
Systematic study of the reaction kinetics of lipid per-
oxidation has shown that the process, is rather complicated 
(Vladimirov and Archakov, 1972). The chemical process of lipid 
peroxidation (Mead, 1976 and Poyer, 1976) is defined as the 
reaction of an oxidant initiator with a pollyunsaturated fat (LH) 
to form a lipid-free radical intermediate{L ), a peroxy free 
radical (LOO*) then forms when oxygen reacts with this free 
radical intermediate. A relatively non-specific hydrogen abstrac-
tion reaction is initiated when the unpaired electrons of the 
peroxy free radical react with another lipid molecule: 
L* + 0^ LOO* 
LOO* + LH — LOOH + L* 
The peroxy free radical can also react with an antioxidant to 
terminate the reaction chain: 
LOO* + Vitamin E LOO + Vitamin E Oxidized 
The nature of the primary free radicals generated in living 
cells and able to initiate lipid peroxidation reactions remains 
one of the most challenging problems. Theoretically, there are 
three types of radicals may be considered as possible candi-
dates for this function:(l) Semiquinones participating in 
electron transport in respiratory chains, (2) Organic molecular 
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free radicals, and (3) Free radicals created by sequential 
* _ * 
addition of electron to oxygen molecule 0_ and OH. 
The "active forms of oxygen" have become a matter of 
grovjing interest (Fridovich, 1974a,b; Beveris et al», 1972). 
Presence of active oxygen molecule (0" , 0^ and OH) and their 
involvement in the processes such as hydroxylation of unnatural 
compounds, lipid peroxidation and cell injuiy phenomenon have 
been studied by Rosenthal (1976) and Hamberg et al. (1974). The 
oxygen radical receiving the most attention is the superoxide 
radical. In fact superoxide radicals never exist alone in water 
solution but spontaneously create all forms of "active oxygen" 
in the sequence of reactions (Fong et al., 1973; Merzljak and 
Sobolev, 1975): 
* _ * - +2H'^  1 
°2 -^  °2 ^^^^A^^o^ir- "2°2 + °2 ^Single oxygen) 
dismutation 
* — * — 4'''H 3 
0^ + O2 ~ ^2^2 "^  ^^ 2 ^^ s^ '^-'- "triplet oxygen) 
H2O2 + Fe'^  (if available) Fe + OH + OH 
It is interesting that moderate amounts of superoxide 
dismutase slightly increased lipoperoxidation, probably because 
of an increase of H^C^production, which, in turn, would 
increase the rate of formation of OH: 
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* _ 
202 
Superoxide 
dismutase 
n"" .1., TT n __...,...,,. .. 
°2 ' "2°2 
n I. t in ,r, m T 
u ^ -r IJU 4' Ul 1 
Any system in cell producing superoxide radicals should 
initiate the lipid peroxidation as f ollov/s: 
2+ -
From Fe or O2 
0 — ^ "0" -> HpO^ '—> OH 
Oxidase or Spontaneously or 
spontaneously by superoxide 
0^ ^ OH" + L 
Chain lipid peroxidation 
Hov/ever, the activation of oxygen is not the only mechanism 
of activation of lipid peroxidation; the process is a chain 
reaction by its nature, and the influence on the proceeding of 
the reaction may also be the key mechanism of lipid peroxidation 
regulating in the cell. 
The problem of the controlling mechanisms of lipid peroxi-
dation in the cell has become more and more complex (YU.A. 
Vladimrov et al., 1930). The administration of exogeneous 
antioxidants will not only inhibit lipid peroxidation but also 
restore the high level of thiols because of the lower concen-
tration of hydroperoxides formed in the chain reaction. Recently 
Tayyaba and Hasan (1985) reported that an antioxidant vitamin E 
significantly inhibit the lipid peroxidation in organophosphate 
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treated brain tissue. To my knowledge, the effect of organo-
phosphate pesticides on the rate of lipid peroxidation are 
limited and perticularly, the effect of organophosphate-
metasystox on lipid peroxidation is not known, therefore, it 
v\?ould be of particular interest to investigate the rate of 
lipid-peroxidation in different regions of rat CNS after the 
administration of three different doses of organophosphate-
metasystox* 
1.24.0 Action of Lipases 
Enzymes hydrolyzing triglycerides have been studied for 
well over a hundred years. In 1846 Claude Bernard demonstrated 
lipase activity in the pancreas and Marcet described ganstric 
lipase in 1858 (Sumner and Somers, 1953). Hov^ ever, White 
et al. (1978) has described phospholipase 'A' and 'B' activity 
in brain. In the brain lipase activity is concentrated more 
in gray matter than in the white (Gozzano, 1934) and certain 
areas, like postrema and caudate nucleus, contain higher 
concentrations than other areas (Ishii, 1957). Intracellular 
distribution experiments have shown that lipases are concentrated 
considerably more in the cytoplasm than in the nuclei (Gomori, 
1946). 
Lipases hydrolyze triglycerides and, products are formed 
in the following sequence. 
6 
Triglyceride 
1,2-Diglyceride 
2,3-Diglyceride 
2 Monoglyceride 
__ — ^ Glycerol + Fatty Acid + Fatty Acid + Fatty Acid 
Rates of lipase reaction can therefore be measured by deter-
mining either (a) the rate of disappearance of the substrate, 
the trilyceride, or (b) the rate of production of the fatty 
acids. The presence of phospholipase-A-like activity in brain 
Was observed by Gallai et al. (1962). These enzymes have been 
useful in study of the structure of phosphoglycerides as well 
as indicating routes of their degradation. The susceptible 
bonds in phosphotidylcholine are indicated by Fig. 6 below 
(V^ite et al., 1973). 
Phospholipase A. i 
H^CO 
Phospholipase 
A, 
—-—-C-
A II 
0 
R 1 
R „^_ 
2 II 
0 
OCH 
Phospholipase D 
c " i "• 
H^CO — ~ — - P ^ OCH^ CHp^ N ZI (CH3) T o 
Phospholipase C O" 
Fig. 6. Action of Phospholipase 
fi2 
Among different brain regions, human cerebral cortex has 
the highest phospholipase Aj^  activity. However, activity in 
the sciatic nerve is very lov/. Most phospholipase Aj_ activity 
is predominantly localized in the microsomes, whereas the 
phospholipase A2 in mitochondria (Goracci et al., 1978). On 
the other hand, the phospholipase A, activity is nonspecific 
in its subsynaptic distribution. Both glial and neuronal 
cell-enriched fractions contain phospholipase A, and A activi-
ties. However, activity in neurons is five-to eight fold higher 
than that in glia. 
Activity of the neuronal phospholipase A is competitively 
inhibited by plasmalogens (Woelk et al., 1973). An increase 
in phospholipase A, and A activities is shown in degenerating 
nerves as early as 2 days after sectioning (vVebster, 1973). 
Phospholipase A, and A_ activities are also elevated in the 
acute stage of experimental allergic encephalomyelitis in rats 
(Woelk et al., 1974 and Vifoelk and Kanig, 1974). 
There are some indications that the lipase (s) in brain 
is stimulated by biogenic amines (Vyvoda and Rowe, 1976). 
The increase in the lipase activity due to organophosphate 
TOCP intoxication is also reported (Shull and Cheeke, 1973). 
To date, no previous report is available on the action of 
lipases in the different regions of the rat brain following 
the administration of organophosphate-metasystox. It is 
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therefore, appropriate to estimate the activity of lipase in 
cerebral hemisphere, cerebellum, brain sten and spinal cord 
in the metasystox-induced toxicosis in rats. 
1.25.0 Vitamin E an Antioxldent 
Some thirty years have passed since the existance of 
vitamin E was recognized, and some twenty years since the 
synthesis of •'^ -tocopherol, the substance with the highest 
known vitamin E activity. The principal group of compounds 
having vitamin E activity are the tocopherols. The seven 
tocopherols which have been found to occur naturally have the 
structures as shown in formula given below. 
3 CH3 CH3 CH3 
r r I 
(CH2)3-CH-(CH2)3-CH-(CH2)3-CH-CH3 
The biopotencies of various tocopherols differ somewhat, 
depending on the assay criteria and animals used. '< -Tocopherol 
has the greatest biological activity however. This could be a 
reflection of its greater extent of methylation. Such methy-
lation will prevent side reactions and lower the oxidation-
reduction potential of hydroquinone-quinone system. The 
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features of tocopherol chemistry that appear most salient to 
possible biological function are its lipoid solubility and 
oxidation properties. They play a physiological antioxidant 
activity (potentiated by ubiquinone QlO)at the cellular level 
by counter acting lipid peroxidation and increasing membrane 
phospholipids suplied by PUFAs and preventing the formation 
of ceroid substance. Vitamin E acts as a H donor in the 
krebs cycle, betv/een the steps of flavin coenzymes (FMH and 
FAD) and of the cytochrome system {Butturini et al., 1955). 
The identification of vitamin E as a fat-soluble vitamin, 
its occurrance in vegetable oils, its storage in association 
\vith body lipids and its possible function as a biological 
antioxidant suggest that a close relationship exists between 
vitamin E and various phases of lipid metabolism. 'iWien vitamin 
E is diffident or completely lacking there is an uncoupling 
of phospholipids and proteins, necessary for the formation of 
cell membrane. In studies in humans, the administration of 
tocopherol to healthy male subjects resulted in increased 
plama cholesterol values (Gray and Loh, 1958). Gray (1959) 
found higher levels of phospholipids and cholesterol esters 
in livers of rats fed 100 mg ^ -tocopherol acetate daily when 
compared vdth livers from unsuplemented,rats presumably due 
to increased hepatic lipid synthesis in the supplemented animals. 
After the pioneering works of Kudrjashov (1937) and Davies 
and Moore (l94l) an appreciable number of scientists have been 
dealing with the relationship between vitamin E and lipid 
peroxidation. The contribution of Tappel's laboratory has 
generally been recognized (Tappel, 1962, 1972, 1973; Vladimirov 
and Archakov, 1972). The increase in lipid peroxidation 
resulting from E-avitaminosis was proved beyond question. The 
activation of lipid peroxidation increase the requirement of 
vitamin E (Witting ', 1970, 1972). Synthetic antioxidants 
prevent symptoms of E-avitaminosis though not completely 
(Roels, 1967; Tappel, 1972). The toxic action of lipid 
peroxidation products (Holman and Greenberg, 1958) which is 
usually inhibited byo(-tocopherol (Kokathur et al., 1966; 
Privett and Cortesi, 1972) an antioxident, on the one hand, 
and the existence of E-avitaminosis symptoms which can not be 
removed by synthetic antioxidants (Roels, 1967; Tappel, 1972) 
on the other hand imply that both the consequences of toco-
pherol difficiency may contribute to the observed macroscopic 
symptoms:the direct dependence of molecular machines of the 
cell on o(-tocopherol and toxic effects of lipid peroxidation 
products. Since organophosphates catalyze the formation of 
an oxidative state in body lipids creating a greater need 
for vitamin E (Hove, 1955; Hove, 1953; Sev;ard et al. 1968)^ 
it is reasonable to postulate the effects of c-C-tocopherol 
on the rate of lipid peroxidation and lipase activity in 
different regions of brain and spinal cord following the 
administration of metasystox an organophosphate. 
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1•26.0 Proteins in the Brain 
Protein, one of the many important biochemical components 
in the vertebrate brain, constitutes 40% of the dry weight 
(Mcllvvain and Eachelard, 1971). This protein content of the 
brain is very constant. There are many kinds of proteins 
present in the brain. Recent evidences suggest the role of 
glycoproteins in the number of specific cell-cell interactions, 
including intercellular adhesion and the mechanisms governing 
neural histogenesis, regional brain differentiation and the 
specificity of neuronal associations (Margolis et al., 1975). 
The changes in the neuronal activity is well accompanied by 
measurable changes in macromolecules like protein in brain cells. 
It has also been reported that the increased neuronal activity 
decreases or inhibits the synthesis of proteins (Hyden and 
Lange, 1972). 
Brain-specific proteins have been described by Moore 
(1965) and Warecka and Bauer (l967). Takehara (1956/1957) 
mentioned the existence of a species-specific fraction and an 
organospecific fraction in the brain proteins. Also Caspara 
and Field (1963) described a brain-specific antigen. The 
S-100 protein of Moore (1965) is distributed in all parts of 
the nervous system, both peripherally and centrally. The 
author suggested that it is probably a neuronal protein composing 
no part of the myelin sheath structure. Recent studies 
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(Uyemura et al., 1967) demonstrated that the S-100 protein is 
heterogeneous. The proteins in the brain are in a dynamic 
state. Synthesis and catabolism have been intensively studied 
by Lajtha (l96l). Protein synthesis can probably start from 
free amino acids, which have to be activated and transferred 
to a soluble ribonucleic acid or nucleoprotein. The changes 
in brain cell RMA suggest that the genetic material of neurons 
and glia is called upon to make adjustments to physiological 
changes by elaborating information and perhaps different 
protein molecules which may themselves be directly involved 
in the nervous activity. 
It has been evidenced that many environmental and nutritional 
factos may bring about the changes in the proteins (Mcllwain and 
Bachelard, 1971). The decrement in the protein concentration 
in many regions of the brain and spinal cord has been observed 
in the rats treated with sublethal dose of phosalone (Kirubagarn, 
1984; Palanivelu, 1984; Tamilvanan, 1984). The decrement in the 
protein concentration in the brain regions of the fishes Labeo 
rohita and Cyprinus carpio has also been reported due to 
ohosalone toxicity (Ravi, 1984). 
Brain, in general, has high rate of metabolic activities. 
It needs more proteins for expected high rate of protein turn 
over. This view is well correlated with the presence of large 
amount of cytoplasmic ribosomes, which gives large num.ber of 
sites for protein synthesis (Mcllwain and Bachelard, 1971). Any 
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change in the protein concentration may influence the metabolic 
rate of the tissue. It requires rapid synthesis and renewal of 
protein. To analyse this view, in the present work, an attempt 
has been made to study the changes in the regional brain protein 
concentration due to metasystox treatment. 
1.27.0 Nucleic acids and Nucleic Enzymes (PNase and RNase) 
of the Central Nervous System 
Nucleic acids in the central nervous system,' as in other 
organs are characterised by their size,' composition, and role 
in protein synthesis. Recent reports suggest that, in addition 
to the established role of nucleic acids in the biosynthesis of 
protein (Campbell, 1965), RI-^A and protein synthesis may be involved 
in the accrual of sensory information in the brain, thus indicating 
a possible approach to elucidation of brain function on a mole-
cular basis (Hyden, 1964). Since the majority of the cells in 
brain are diploid, there is generally a fixed quantity of DNA 
per cell. Some polyploidy has been reported in brain cells: 
however, the number of these cells is relatively small (Viola, 
1963). In general HJA 'content in mammalian brain is between 
6.1-7.1 Pg/Cell(Heller and Elliott, 1954). The ENA extracted from 
human cerebral gray matter had an A •¥ T/G+C ratio of 1.48,"' while 
the white matter had a ratio of 1.41. The actual content 
of DNA Was reported to be 0.50 mg/g fresh weight in human 
gray matter and 0.72 mg/g fresh weight in white matter 
(Robinson, 1966). The base ratio for ENA does not change in 
various regions of the rat brain nor even among the various 
mammalian brain. 
Any enzyme that breaks down DMA has been at times, 
called a deoxyribonuclease. An acid and an alkaline DNase 
have been identified in infant and adult rat brain (Sung, 1968). 
The latter enzyme shows a strong preference for denatured DNA. 
On the other hand the acid DNase prefers native DNA. In the 
brain of senescent rats, DNase activity was found to be twice 
as high as that in young adult animals (Asano et al., 1979). 
With regard to cellular localization, neuronal nuclei prepared 
from young and adult rat brain have been shown to have a higher 
DNase activity than glial nuclei (Stanmbolova, 1973). 
It has been reported that organophosphate DDVP-induces 
degenerative changes in neurons and nerve fibres. The results 
with organophosphate pesticide metasystox in rats show that 
there is a remarkable decrease in the DNA level in all the 
brain regions that are analysed. This has been correlated with 
increased DNase activity (Tayyaba et al., 1981). The available 
literature on DNA and DNase indicate that the knowledge of 
organophosphate toxicity on brain nucleic acids and nucleic 
enzymes is inadequate. It is therefore, appropriate to estimate 
the level of DNA and the activity of DNase in cerebral hemisphere, 
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cerebellum, brain stem and spinal cord after metasystox 
toxicosis in rats. 
The studies of H^ A concentration are of interest to know 
the rate of protein synthesis and also to understand the 
functional status of the nervous tissue (Bergen, et al., 1974). 
Edstrom (1956) and Edstrom and Pigon (1958) have reported that 
there is a proportionality between RMA content and the surface 
area of the cell body. The perikarya contain more M A than the 
axons. There is a decrease in RiNA concentration along two-thirds 
of the axon distal to the hillock, then the PWA increases towards 
the distal end of the axon Edstrom (1956 )• In contrast to the 
glia the neurons contain more RNA by a factor of approximately 
thirteen (Hyden, 1962)* Hyden has demonstrated that the content 
of M A in neurons varies over a wide range. Jacob et al.(l966) 
isolated RNA from rat brain combined samples of cerebral cortex, 
cerebellum, and brain stem. 
In vertebrate animals, extra cellular Rlslases are secreted 
by the pancreatic and by the salivary glands (Ellem and 
Colter, 1963). The usual function of an RNase is, rather 
obviously, to break down RNA. This, however, tells very 
little about the actual physiological actions of these enzymes. 
The response of Rl\iA/and RNase to neurotoxicants like organo-
phosphate compounds has been reported (Tayyaba et al., 1981). 
However, information on the dose dependent effect of oraano-
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phosphate nfietasystox on the ribonucleic acid metabolism is 
still lacking. It is therefore, appropriate to estimate the 
levels of RMA and RNase activity in different regions of brain 
and spinal cord after metasystox administration. 
J-• 23.0 Specific Objectives of this Study 
The present study was undertaken with the following main 
aims: 
i) To evaluate the normal concentration of various lipid 
and nucleic acid components in the different regions of the 
rat brain. 
ii) Quantitative evaluation of the effect of metasystox-
intoxication on the concentration of total lipids, phospholipids, 
cholesterol, C/P Ratio, esterified fatty acids, gangliosides, 
lipid peroxidation and lipase activity. 
iii) To estimate the levels of DNA, RNA, protein and the 
activity of DNase and RNase following the administration of 
metasystox in various brain regions. 
iv) Qualitative evaluation of total lipid, phospholipid, 
nucleic acid and the activity of lipase in the cerebral 
hemisphere. 
v) To evaluate the effects of vitamin E on the rate of 
lipid peroxidation and the activity of lipase alone and in 
combination with metasystox. 
2.0 MATERIALS AND METHODS 
2.1.0 Qrqanophosphorus Compound and Other Chemicals; 
The organophosphorus compound used in this study was 
metasystox (0,0-dimethyl-S-2(ethylsulphinyl) ethylthiophosphate) 
obtained from Bayer (India) Ltd., Bombay-1. Other chemicals 
like ribonucleic acid, deoxyribonucleic acid (RNA and ENA), 
lipase substrate, trizma buffer, thymolphthalein indicator were 
purchased from Sigma Chemical Co., U.S.A. Rest of the chemicals 
were purchased from B.D.H., Sarabhai and E. Merck Chemicals 
(India) of analar grade. 
2.2.0 Experimental Animals: 
One hundred twenty six male adult rats (Rattus rajah) 
weighing 180 + 20 g, obtained from Central Animal House, J.N. 
Medical College, A.M.U., Aligarh, were used in this study. They 
were allowed free access to pellet diet (Hindustan Lever 
Laboratory Feeds, India) and water. The pellet composition 
corresponded to nutritional standards recommended by the U.S. 
National Research Council's Publication No. 990, entitled: 
"Nutritional Requirements of Laboratory Animals". The animals 
were acclimated for 15 days in accordance with the instructions 
given by Behringer (1973). 
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1. The animal room and the cages were cleaned daily to keep 
them dust free. 
2. The size of the metal cage was 18" x 12" x 6" in which two 
rats were lodged. 
3. The rats were fed with rat food p§llets prepared by-
Hindustan Lever Ltd., Bombay and clean drinking water was 
provided ad. libitum-
4. Light and darkness of the animal room was maintained as 
12 hrs. 
5. The rats showing symptoms of disease were removed immediately 
after identification. 
2.3.0 Dissection of the Brain Parts and Spinal Cord 
Rats were sacrificed by decapitation. The brains were 
dissected out into cerebral hemisphere, cerebellum, brain stem 
and spinal cord as shown in Fig*^ S-S according to the method of 
McEwen and Praff (1970). They were weighed to the nearest 
milligram on a single pan electric balance. 
2.4.0 Administration of Drug; 
Animals were divided into six groups. A freshly prepared 
solution of metasystox in normal saline was injected in three 
different doses (1,2 and 4 mg/kg body weight i.p. daily for 
10 days) to each rat of group 2, 3 and 4 respectively. The rats 
EXPLANATION OF THE FIGURE 
Fig. 7: Photograph showing dissected rat brain (dorsal view). 

EXPLANATION OF THE FIGURE 
Fig» 8 : Sagittal Section of rat brain,' showing land mark 
used and region obtained in dissection procedures. 
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of group 1 served as control and were given an equal volume of 
physiological saline concurrently, a-tocopherol (150 lU/kg body 
weight) was injected intraperitoneally daily for 10 days, to 
each rat of the group 5. The animals of group 6 were administered 
metasystox (2 mg/kg body weight) in combination with a-tocopherol 
i.p. daily for 10 days. 
2.5.0 Extraction of Lipids from Discrete Brain Areas 
Different parts of the brain, weighing 150-300 rag, were 
homogenized in a glass homogenizer to a final volume of 6 ml 
chloroform-methanol (2:1 v/v) according to the method of Folch 
et al. (1951). This method was partly modified in our laboratory 
(Islam et al., 1980) for isolation of lipids, from discrete areas 
of the brain. Each homogenate was shaken periodically for an 
hour and filtered under vacuum through a sintered funnel (G-4) 
(Fig. 9 ). The residue of each test tube was again homogenized 
with 2 ml chloroform-methanol and filtered. The test tubes were 
rinsed with fresh chloroform-methanol (2:1) and again filtered.-
The final volume of each extract was made to 10 ml with fresh 
chlorofomt.methanol mixture* Thereafter, 2.5 ml of saline 
solution Was added to the extract in each test tube (4:1, v/v). 
This was shaken vigorously on test tube mixer for thorough 
mixing and placed at -20 C in a deep freeze overnight for complete 
separation of the two layers. The junction of the layers of each 
test tube was marked, the upper layer was used for the estimation 
of gangliosides and desired amount of the lower layer of each 
EXPLANATION OF THE FIGURE 
Fig. 9 : Filter adaptor and sintered glass funnel for the 
quick filtration of brain lipid homogenate directly 
in 18 X 150 mm test tube. Filter adaptor is connected 
to vaccum through the side arm tube. 
Fig. 9 
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test tube was collected in stoppered tubes with the help of 
syringe (Fig.10 ) and stored at -20 C for 24 hours. The test 
tubes, in which the two layers were separated, were dried and 
the volume of the lower layer of each test tube was measured. 
The extract was used for the estimation of total lipids, 
phospholipids, cholesterol and esterified fatty acids. 
2.6.0 Estimation of Total Lipids 
Total lipids were estimated according to the method of 
Woodman and Price (1972) as follows: 
2.6.1 Reagents; 
i) A standard solution of 0.5 mg brain/ml of chloroform-
methanol (2:1) was prepared by diluting 1.0 ml of 
refrigerated stock solution (50 mg brain/lO ml, 
chloroform-methanol 2:1) in a 10.0 ml standard flask 
and volume was made up to 10.0 ml with chloroform-
methanol mixture. 
ii) Concentrated sulfuric acid A.R. 
iii) Coloring reagent; 6.0 g potassium dihydrogen ortho-
phosphate and 0.39 g vanillin were dissolved by heating 
in 100.0 ml volumetric flask and volume was made up to 
100.0 ml with double distilled water (DDW). 
2.6.2 Brain Lipids; Lipids were extracted from 3 rat brains in 
S-i 
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50.0 ml chloroform-methanol mixture. The honaogenate was centri-
fuged at 5000 rpm for 15 rain. The supernatant was taken in a 
separating funnel and washed thrice with an equal volume of 
physiological saline and the lower layer was collected after 
15 min. of each washing. After final washing the lower layer 
was kept in a refrigerator overnight for the complete separation 
of the two layers. The lower layer was collected in a 15 cm 
diameter petridish and the solvent was evapoirated at room tempe-
rature by continuous shaking of the petridish. The dried lipids 
were again dissolved in chloroform-methanol mixture and centrifuged 
to remove undissolved lipids. The extract was once again evapora-
ted in a petridish and dried lipids were stored at -20 C. 
2.6.3 Procedure; Duplicate brain samples, containing 0*1 ml of 
the aliquots, were taken in 18 x 150 mm corning test tubes. 
Concentrated H2S0^(2.5 ml) was added to each test tube and heated 
on a boiling water bath for 20 min. After cooling, 5.0 ml of 
coloring reagent was added to it and absorption was read at 530 nm, 
exactly after 10 min against a reagent blank. A calibration curve 
was prepared by taking different concentrations (50 to 500 ^ g) of 
standard brain lipids by adopting the same procedure as described 
above. The values of the standard curve were plotted by least 
square method. The concentration of total lipids in brain samples 
were calculated by the formula given below. 
2.6.4 Calculation; 
Total lipids (mg/g fresh wt.) = C x V/Vt x wt 
81. 
C =: Concentration of lipids in ^q in 0,1 ml brain extract. 
(Volume taken for estimation) 
V = Total volume of the lower layer. 
Vt = Volume taken for the estimation. 
Wt = Fresh weight of the tissue in mg. 
The above formula was used for calculating the concen-
tration of total lipids, phosphate, cholesterol and esterified 
fatty acids. 
2.7.0 Estimation of Phosphate; 
Phosphate was estimated by the well known method of 
Fiske and Subbarow as described by Merinetti (1962) by utilizing 
the following procedure. 
2.7.1 Reagents; 
i) A standard of 0.01 mg/inorganic phosphate/ml was 
prepared by the dilution of 5.0 ml of refrigerated 
stock solution (0.43 g KH^PO^/SOO.O ml DDW) in a 
100.0 ml volumetric flask and volume was made up to 
lOO.O ml with DDW. 
ii) Ammonium molybdate solution 2.3% was prepared by 
heating in a boiling water bath, 
iii) Perchloric acid 70% A.R. 
iv) Reducing reagent; Sodium bisulfite 3.0 g (Sigma 
Chemical Co., U.S.A.), sodium sulfite 0,6 g (May & 
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Baker, U.K..) and a recrystallized l-Amino-2-napthol-
4-sulfonic acid (ANSA) 0.05 g were dissolved in 
25 ml DDW. A slight yellow solution thus obtained 
was stored in amber colored bottle. The color is 
stable for a week at the room temperature. 
v) Recrystallization of ANSA: Sodium metabisulfite 
15.0 g, sodium sulfite (anhydrous) 1.0 g and crude ANSi^  
1.5 g were dissolved in 100.0 ml of boiling DDW. Hot 
solution was filtered through the filter paper. 1.0 ml 
concentrated HCl was added to the filtrate and 
stirred. The precipitate was filtered through the 
suction pump and washed with about 30.0 ml double 
distilled water and finally with alcohol till 
washing is colorless. This purified ANSA is dried 
in oven at 100 C for 1 hour with least possible 
exposure to light. This was transferred to an 
amber colored bottle. 
2.7.2 Procedure; Brain aliquots 0.1 ml in duplicate were 
pipetted in 18 x 150 mm corning test tube and all the solvent 
was removed by heating on a boiling water bath. 1.0 ml of 
analytical grade lO/o perchloric acid was added to the samples 
and heated on a digester for 30 min or until the samples become 
clear. After the complete digestion, they were cooled at the 
room temperature. Thereafter, 1.5 ml ammonium molybdate, 
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0.2 ml reducing reagent (ANSA), and 7.0 ml double distilled 
water were added to it. The contents were mixed after each 
addition. The tubes were heated on a boiling water bath for 
7 min. The color intensity was read at 700 nm after 30 min. 
A calibration curve was drawn by taking 1 p,g to 8 pg of 
phosphorus and the blank was prepared with 1.0 ml perchloric 
acid alone. Similar procedure was adapted as described above, 
and the value of the calibration curve were plotted by the 
least square method. The absorption is a linear function of 
the phosphorus content and the amount in unknown samples can 
be calculated by direct proportion with the absorbance obtained 
for the standard. The amount of phospholipid was calculated by 
multiplying the values with a factor 25. 
2.8.0 Estimation of Cholesterol: 
Cholesterol was estimated by Lieberman-Burchard reaction 
as described by Bloor et al. (1922). 
2.8.1 Reagents; 
i) Standard solution of cholesterol 1.0 mg/ml in 
chloroform was prepared by the dilution of 1.0 ml 
refrigerated stock solution of recrystallized 
cholesterol (100 mg/ml) in a 10.0 ml standard flask 
and volume was made up to 10 ml with analytical 
grade chloroform. 
ii) Color reagent; Analytical grade acetic anhydride, 
50.0 ml, was kept in deep freeze for an hour and 
5.0 ml concentrated analytical grade sulfuric acid 
was added dropwise with stirring. The reaction 
mixture was allowed to stand for additional 10 min 
at room temperature before use. This reagent was 
prepared fresh each time it was used. 
2.3.2 Procedure; Aliquots of brain extracts, 0.5 ml were taken 
in 15 X 125 raai screw capped culture tubes. To each tube, 
4.5 ml analytical grade chloroform and 1.0 ml of coloring 
reagent were added and mixed. The tubes were kept in 
dark at 25 C for 30 min. The color intensity was read at 
660 nm against a reagent blank. A calibration curve with 
different concentrations of cholesterol (100-800 \xq) was 
drawn according to the same method as described above. 
The values were plotted by the least square method and 
concentration of the cholesterol was calculated as in 
the case of total lipids. 
2.9.0 Estimation of Esterified Fatty Acids 
The analysis of esterified fatty acids was performed by 
using the method of Stern and Shapiro (1953). 
2.9.1 Reagents; 
i) Standard solution; A standard solution of 4.0 meq of 
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triolein in alcohol-ether (3:1) v^ as prepared by-
dilution of 1.0 meq stock solution (59 rag triolein 
in 5 ml alcohol-ether, (3:1) to the final volume of 
10.0 ml with alcohol-ether mixture. 
ii) 2.0 M Hydroxylamine hydrochloride (Solution I);13»9 g 
of hydroxylamine hydrochloride was dissoived in double 
distilled water by dilution to 100 ml. 
iii) 3.5 N Sodium hydroxide (Solution II); 14.0 g of 
sodium hydroxide was dissolved in 100 ml double 
distilled water. 
iv) Hydroxylamine-sodium hydroxide; It was made before 
using by mixing equal volume of solution I and II. 
v) 0.37 M Ferric chloride (FeCl3 in 0.1 N HCl): 6.0 g FeClg 
was dissolved in 100 ml of 0.1 N HCl. 
vi) 4.0 N Hydrochloric acid solution (Approximately); The 
solution was prepared by adding 1 part of analytical 
grade concentrated HCl to 2 parts of double distilled 
water. 
vii) Alcohol-ether (3;l) mixture: 3 Parts of 95% ethanol 
were added to 1 part of ethyl ether (peroxide free). 
viii) Peroxide free Ether; A little of hydroxylamine 
hydrochloride was added to the stock ether bottle 
prior to distillation of ether. The ether used in 
the procedure was freshly distilled. 
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2.9.2 Procedure; Aliquots of brain extracts, 0.2 ml were 
pipetted in 16 x 150 mni screw capped culture tubes, and 
dried at room temperature. Then 3.0 ml aliquot of the 
alcohol and ether (3:l) was pipetted to each tube and 
1.0 ml of hydroxylamine hydrochloride solution was added, 
the contents were mixed and allowed to stand for 20 min. 
at room temperature. Thereafter, 0.6 ml of 4 N HCl and 
0.5 ml of ferric chloride solution were added to it and 
mixed after each addition. A dark brown color developed 
which was measured at 520 nm against a reagent blank. 
A calibration curve was drawn by using 0*1 to 0.6 ml 
of the standard solution (4.0 eq/ml) and the volume was made 
up to 3.0 ml with alcohol-ether mixture and the procedure was 
carried out as described above. 
2.9.3 Calculations: 
Meq esterified fatty acid = 0^-Ofunknown x meq of standard 
in 3.0 ml aliquot °-°- °^ standard 
2.10.0 Estimation of Ganqliosides: 
Gangliosides were estimated according to the method of 
Pollet et al. (1978) essentially as follows: 
2.10.1 Reagents; 
i) Standard solution; A standard solution of 100 meg 
N-acetyl neuraminic acid (Sigma Chemical Co., U.S.A.)/ 
ml double distilled water was made by diluting 1.0 ml 
of the refrigerated stock solution (lO.O mg N-acetyl 
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neuraminic acid/lO ml double distilled water) to the 
final volume of the 10 ml with double distilled water. 
ii) Resorcinol reagent; This reagent was prepared by 
mixing 10.0 ml of 3% resorcinol solution in DDW, 80 ml 
of concentrated HCl, 0»25 ml of 0.1 M copper sulfate 
and water upto 100.0 ml. 
2.10.2 Procedure; To 2.0 ml of the upper layer of the lipid 
extract was added 2.0 ml of resorcinol reagent. The 
test tubes were heated in boiling water bath for 30 rain. 
After cooling 5.0 ml of a mixture of butyl acetate-n-
butanol (85;15, v/v) was added to each tube. The tubes 
were shaken thoroughly and kept for 15 min to separate 
the organic phase. About 3-4 ml of organic phase was 
taken and absorbance was measured at 580 nm against 
reagent blank. A standard curve with different concen-
trations of N-acetylneuraminic acid (5-30 meg) having 
2.0 ml final volume of water was prepared by treating 
similarly. 
2.10.3 Calculation; 
Gangliosides (mg/g fresh wt.) = y. ^ ^r 
C = Concentration in p,g in 2.0 ml extract 
V = Total volume of the upper layer 
Vt = Volume taken for the estimation 
Wt = Fresh wt. of the tissue in mg. 
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2.11.0 Determination of the Rate of Lipid Peroxidation 
The amount of malonaldialdehyde formed/30 minute during 
lipid peroxidation was estimated according to the method of 
Utely et al. (1967) as described below: 
2.11.1 Reagents: 
i) 0.15 M - Potas slum chloride: 2.2368 g of KCl was 
dissolved in 200 ml double distilled water. 
ii) 10^ (w/v) Trichloroacetic acid: 10.0 g TCA was 
dissolved in 100 ml double distilled water. 
iii) 0.67% 2-thiobarbituric acid (TBA): This was 
prepared by dissolving 0.67 g of TBA in 25-50 ml 
double distilled water by adding two pellets of NaOH 
and volume was made up to 100 ml with double distilled 
water. The pH of the solution was adjusted to 7.2 
with the IN HCl. 
2.11.2 Procedure: Different parts of the brain were homogenized 
(10^ w/v) in chilled 0.15 M potassium chloride. One ml of each 
homogenate was taken in 25 ml conical flask and incubated at 
37 + 1 C in a metabolic shaker (120 strokes/min; amplitude 1 cm) 
for 3 hours. After incubation, 1.0 ml of IC^o TCA was added to it 
for the precipitation of protein. Thereafter 1.0 ml of each 
reaction mixture was pipetted in centrifuge tubes and centrifuged 
at 3,000 rpm for 10 minutes. One ml of the clear supernatant was 
sn 
mixed with l.G ml 0.67% TBA and 1.0 ml double distilled water. 
The test tubes were placed in a boiling water bath for 10 min. 
cooled and the absorbance of the coloring solution was read at 
535 nm. The rate of lipid peroxidation is expressed as nanomoles 
of malonaldehyde formed per 30 minutes using extinction coeffi-
5 , , 
cient 1.56 x 10 as described by Utely et al. (1967). Lipid 
peroxidation was calculated using the following formula: 
Where, X = nanomoles of malonaldialdehyde formed/30 minute 
O.D. = change of optical density at zero hour and 
three hour incubation of the same samples 
V - 0»D» x 30 X 1000 x 1000 x 1000 x 3 x 2 
1.56 X 100000 X 1000 x 180 
P.P. X 10 
^ ~ 1.56 
2.12.0 Determination of Lipase Activity 
The activity of lipase was measured by the method of 
Tietz and Fiereck (1966). This procedure was partly modified 
in our laboratory (Haider et al., 1981) for the determination 
of lipase activity in various regions of the brain as described 
below: 
2.12.1 Reagents; 
i) Lipase substrate (Sigma Chemical Co.. U.S.A.); It 
contained 50% olive oil (v/v) and sodium Azide 0.1% 
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as preservative. It was kept in a refrigerator at 
5 C and shaken thoroughly before use. 
ii) Trizma Buffer; Reagent grade tris 0.2 M(hydroxymethyl) 
aminoethane (Sigma Chemical Co., U.S.A.) dissolved in 
double distilled water, pH 8.0 at 25 C and sodium 
azide iO»l%) as preservative. It was stored at room 
temperature. 
iii) Thymolphthalein Indicator Solution; 0.9% thymol-
phthalein (w/v) in ethanol. 
iv) Ethyl alcohol, 95%. 
v) 0.05N, sodium hydroxide. 
2.12.2 Procedure; Various parts of the brain were homogenized 
(10% w/v) in chilled 0«15 M potassium chloride. The homogenates 
were centrifuged at 5000 rpm for 20 minutes. Thereafter one ml 
of the supernatant of each part of the brain was pipetted in a 
50 ml conical flask marked 'BLA^ ]K' and was placed at 0 C for 
3 hours. Then two sets of the test tubes were taken, one set 
was marked 'TEST' and other as 'BLANK'. One ml aliquot of 
each part of the brain was taken only in the set of test tubes 
marked 'TEST' thereafter, into both sets of test tubes (TEST 
and BLANK) were pipetted 3.0 ml lipase substrate, 1«0 ml trizma 
buffer and 2.5 ml of double distilled water. Sets of both test 
tubes were placed in a constant water bath at 37 C for incubation 
for 3 hours. After the incubation, contents of the test tube 
(TEST)were poured into 50 ml flask and marked 'TEST'. 
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The contents of the test tube (BLANK) were poured into the 
'BLANK' flask which was kept at 0 C. Sets of both test tubes 
were rinsed with 3.0 ml alcohol and poured into their res-
pective conical flasks. To both sets of the flasks, 6 drops 
(0.25 ml) of thymolphthalein indicator were added and titrated 
with 0.05 N NaOH to a light blue color. 
2.12.3 Calculation; Volume (ml) of NaOH used for TEST-Volume 
(ml) of NaOH used for blank = 5 
Brain Lipase activity in International Unit per gram 
(lU/g) = S X 10 X 0.28 
Brain lipase (lU/g) = S x 2.8 
where, 0.28 a multiple factor. 
2.13.0 Histochemical Staining of Total Lipids 
Sudan black B method of Lison and Dagnelie (1935) was 
used for the histochemical study of the total lipids as 
described below: 
2.13.1 Reagents; 
Solution A; Sudan black B 1% in isopropanol. 
Solution B; Sodium borate i% in DDW. 
Solution C; Solution A and B were mixed in equal parts 
and allowed to stand for 10 min at room 
temperature and then filtered. 
n 
Formol calcium solution; Calcium chloride 1 g or calcium 
acetate 1 g was dissolved in about 50 ml of DDW. To this 
solution, 10 ml formaldehyde (40%) was added and the volume 
was made up to 100 ml with DDW. 
Glycerin .jelly; Gelatin 15 g were dissolved in 100 ml DDW 
with moderate heating (60 C) then 100 ml glycerol was added 
and the solution was mixed well. Thereafter, it was filtered 
through glass-wool whilst hot. The bulk was stored in 
refrigerator. 
2.13.2 Procedure; 
Formol calcium fixed frozen section, 10 n in thickness 
were cut on a freezing microtome. The sections were mounted 
on glass slides and dried by air at room temp. They were 
washed with DDW and stained for 10 min. in solution C. They 
were differentiated in 60% isopropanol and washed with DDW. 
The sections were counterstained with a red nuclear dye 
(carmalum 0.1%) and mounted in glycerin jelly after washing 
the section with DDW. Lipid material, including phospholipids 
stained black and nuclei red. 
2.14.0 Histochemical Staining of Phospholipids 
Osmium tetraoxide a-naphthylamine (OTAN) method (Adams, 
1959) was used for the histochemical study of the phsopholipids 
as described below; 
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2.14.1 Reagents: 
i) Osmium tetraoxide 1% in DDW. 
ii) Potassium perchlorate 1% in DDW. 
iii) Naphthvlamine solution; Saturated solution of 
a-naphthylamine in warm DDW (p-naphthylamine may 
be a contaminant and is a carcinogen, and hence care w 
Was exercised). 
2.14.2 Procedure; Formol calcium fixed frozen sections of 
10 |i thickness were cut on a freezing microtome. Free 
floating sections were treated for 18 hours with osmium 
solution (l part 1% osmium tetraoxide and 3 parts of 1% 
potassium perchlorate) in a 100 ml stoppered conical 
flask filled half with the osmium solution and stoppered 
tightly. After 18 hours, osmium solution was decanted 
and sections were washed with DDW for 10 min. in 
petridish. The washed sections were picked up on glass 
slides. Sections were dried by air at room temp, and 
treated with a-naphthylamine solution in a coupling 
jar for 20 min. at 37 C. The sections were washed with 
DDW for 5 min. and mounted in glycerin jelly. Phospho-
lipids gave orange red color. 
2.15.0 Localization of Lipase; 
Lipase is a hydrolyzing enzyme of triglycerides which 
has been localized in the rat brain by the following Tween method. 
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Tween method (after Gomori as cited in Pearse, 1961): 
1. 5% Tween 100 ml 
2. 0.5M-tris (hydroxymethyl)aminomethane 
buffer (pH 7.2-74) 
3. Dilute yellow ammonium sulphide 100 ml 
Incubation Medium 
Buffer 5 ml 
CaCl2 2 ml 
Tween solution 2 ml 
Distilled water 40 ml 
A crystal of thymol is added for preservation. Fresh 
frozen sections of 12 M- thickness were incubated for 6 hours 
in the incubation medium, immersed in 1% lead nitrate for 
15 minutes and treated with dilute yellow ammonium sulphide 
for 2 minutes. A brown-black precipitate indicate the 
presence of lipase. 
2»i6.0 Isolation of Nucleic Acids; 
Nucleic acids were isolated in cerebrum, cerebellum, 
brain stem and spinal cord according to the method of water C. 
Schneider (1957). 
2.16.1 Removal of acid soluble compounds; Onemilliliter of 
a 20^ 0 regional brain homogenate was mixed with 2.5 ml 
9[. 
of cold 10% TCA and centrifuged. The sediment was 
washed once with 2.5 ml of cold 10% TCA. 
2»16»2 Removal of lipoidal compounds: The final sediment 
remaining after removal of the acid soluble compounds 
Was extracted twice with 5 ml of chloroform methanol 
(2:1) according to the method of Folch et al« (1955) 
and recovered by the filtration on sintered glass 
funnel 6-4 of 35 ml capacity (corning). 
2.16.3 Removal of nucleic acids; Lipid free tissue residue 
was suspended in 2.5 ml of 10% TCA and heated for 15 min. 
at 90 C with occasional stirring. This treatment 
quantitatively splits both DNA and RNA from the tissue 
proteins and leave the latter as an insoluble residue 
which was centrifuged off and washed with 2.5 ml of 5% 
TCA. The combined extract was used for the estimation 
of DNA and RNA in the different regions of the rat brain. 
2.17.0 Estimation of DNA; 
DMA was estimated according to the method of Dische 
(1930) as follows: 
2.17.1 Reagents: 
i) 25 mg DNA was dissolved in 25 ml trisbuffer of pH 
7.0. 
% 
ii) Diphenylamine reagent; One gram of purified 
diphenylamine was dissolved in 100 ml of analytical 
grade glacial acetic acid and 2.75 ml of analytical 
grade concentrated sulphuric acid. It is convenient 
to prepare it immediately before use. 
iii) Recrvstallization of diphenylamine; 10 g diphenyl-
amine was boiled in about 25 ml hexane. The mixture 
was allowed to stand at room temperature and while 
stirring crystals were filtered on sintered glass 
funnel (G-4). 
2.17.2 Procedure; One milliliter of the nucleic acid extract 
was mixed with 2.0 ml diphenylamine reagent and was 
heated for 10 min in boiling water bath. The intensity 
of the blue color was read at 600 nm. As standard curve 
with the different concentrations of ENA (100-600 meg) 
was drawn according to the same procedure as described 
above. The values were plotted by the least square 
method. 
2.18.0 Estimation of RNA; 
JFiNA was estimated according to the method of Volkin 
and Cohn (1964) as follows; 
2.13.1 Reagents; 
i ) Orcinol reagent; One g of purif ied prc inol was 
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dissolved immediately before use in 100 ml of concen-
trated HCl containing 0.5 g of FeClo • 
ii) Purification of orcinol; Since commercial orcinol 
can vary in color from light pink to brick red, so 
we have purified it. 10 g Orcinol was boiled in 25 ml 
benzene and 5.0 g charcoal was added to this mixture 
for decolorization and filtered on sintered glass 
funnel G-4. A perfectly white crystal was obtained 
by adding hexane. 
2.18.2 Procedure; To 1.0 ml of nucleic acid extract 1.5 ml of 
orcinol reagent was added and the mixture was heated in 
boiling water bath for 20 min. The intensity of the 
green color was read at 660 nm. A calibration curve with 
the different concentrations of BNA (100-600 ug) was drawn 
according to the same procedure as described above. The 
values were plotted by the least square method. 
2.19.0 Extraction of RNase and DNase from Rat Brain: 
Different parts of the brain tissue were homogenized in 
Tris HCl buffer of pH 7.5 to give 20% (w/v) homogenate and 
centrifuged for 10 min at 15,000 rpm at 0°C. 0.5 ml of native 
DNA (2 mg/ml) was taken in centrifuge tubes- 0.1 ml of 0.5 M 
Tris HCl buffer of pH 7.5, 0.2 ml of double distilled water and 
0.2 ml supernatant was added to make the reaction mixture 
1.0 ml. Test tubes were incubated at 37°C for an hour. After 
an hour incubation 0.2 ml BSA (10 mg/ml) and 1.2 ml (14%) 
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perchloric acid were added. All the tubes were kept in an ice 
bath again for an hour. Supernatant was taken after centri-
fugation of the tubes at 400 rpm. 
2.20.0 Estimation of ENase; 
Activity of DNase was measured according to the method 
of Sung (1968) as follows: 
2.20.1 Procedure; 1 ml aliquote was mixed with 2 ml of diphenyl 
amine reagent and kept in boiling water bath for 20 min. 
Intensity of blue color was read at 600 nm. 
2.21.0 Estimation of RNase; 
RNase activity was measured according to the method of 
Mac Donald (1955) as follows: 
2.21.1 Procedure; 1 ml of aliquote was mixed with 3 ml of 
orcinol reagents and kept in a boiling water bath for 
20 min. The intensity of green color was read at 
660 nm. 
2.22.0 Estimation of Protein: 
Protein was estimated according to the well known 
method of Lowry et al. (1951) as follows: 
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2.22»1 Reagents: 
i) A standard of 1 mg BSA/ml was prepared in PBS. 
Reagent A; 4% Sodium carbonate in double distilled water. 
Reagent B; 2% Copper sulphate in double distilled water. 
Reagent C; 4% Sodium or potassium tartarate in double 
distilled water. 
ii) Copper Reagent; Reagent A, B and C were mixed in 
the ratio 100:1:1 respectively at the time of the use. 
iii) Folin-Ciocaltau Reagent; A mixture consisting of 
100.0 g sodium tungstate (Na^WgO..2H2O), 25.0 g of 
sodium molybdate (Na^MgO. .2H2O),, 700.0 ml of double 
distilled water, 50.0 ml of 85^ phosphoric acid and 
100.0 ml of concentrated HCl was refluxed in 2.0 
liter flask for 10.0 hours. To this mixture 150.0 g 
of lithium sulphate, 50.0 ml of double distilled 
water and a few drops of bromine water was added and 
boiled for 15.0 min. without condenser to remove 
excess of bromine. The mixture was cooled, filtered 
and volume was made up to 1.0 liter. This mixture 
was diluted 5 times. 
2.22.2 Procedure; In a test tube 0»'2 ml of the supernatant 
of 1% homogenate was taken and 0.3 ml PBS was added and 
it was shaken for complete mixing after adding 5.0 ml 
100 
of copper reagent. After 10.0 min 1»0 ml of the diluted 
Folin reagent was added and intensity of the color was read 
at 700 nm after 30 min. A standard curve of different con-
centration of BSA (100 meg to 600 meg) was plotted in the 
same way as described above. 
2.23.0 Histochemical Localization of Nucleic Acids 
Methyl-green pyronin method (Kurnick, 1955) was used 
for the localization of DMA and RNA. 
(a) Pyronin Y 2 gm 
distilled water 100 ml 
Extracted by CHCl^ 
(b) Methyl green 2 gm 
Distilled water 100 ml 
Extracted by CHClo 
The slides were stained in the above solution for 
6 minutes. DNA stains green and ENA bright red. 
2.24.0 Statistical Analysis 
Results were given as mean + S.E.M.. statistical 
analysis for significance between the means of the experimental 
and control groups was checked by student's 't' test, and the 
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•P' values calculated.'?' values less than 0.05 were consi-
dered be significant. 
2.25.0 Analysis of Variance (ANOVA) 
ANOVA was calculated by using computer "VAX-ll/780". 
The object of ANOVA was to break up the total variation into 
componants due to each of the two factors: 
{ i ) Variation within regions 
( ii ) Variation due to metasystox-toxicosis. 
They were compared by 'F' test. 
3.0 RESULTS 
3.1.0 Physical Signs After Metasystox Intoxication 
Following the administration of metasystox to rats, 
signs such as muscular fasciculation, hyperexcitability to 
tactile stimuli, at times convulsions, staggering gait and 
weight loss were observed. In the vitamin E supplemented 
rats, significant weight gain was noted. But the body 
weight of the rats, after the administration of vitamin E 
in combination with metasystox did not differ significantly 
from the control. 
3.2.0 Calibration of Standard Curves 
The standard curves of d if f erent known concentrations 
of the total lipids, phospholipids, cholesterol, esterified 
fatty acids, gangliosides, ENA, RNA and proteins were cali-
brated against their optical densities respectively. The 
concentration of various lipid fractions was calculated from 
the individual standard curves. 
3.3.0 Effect of Metasystox (1.2 and 4 mq/kq body weight, i.p. 
Daily for 10 Days) on the Lipid Profiles of Rat Brain 
and Spinal Cord 
The data embodied in Fig. 11-15 represent the dose-
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related depletion of total lipids, phospholipids, cholesterol, 
esterified fatty acids and gangliosides in the different 
regions of aSiS following the metasystox (1,2 and 4 mg/kg body 
weight) intoxication. Table-11 shows that at the dose of 
1 mg/kg the concentration of total lipid content was signifi-
cantly decreased in cerebrum (P/O.Ol) and spinal cord (P/O.05). 
However, no significant change was observed in cerebellum and 
brain stem. When the dose of metasystox was increased (2 mg/kg) 
the content of total lipid also depleted from 20.52% in 
cerebral hemisphere, 15.43% in cerebellum, 14.10% in brain 
stem and 18.39% in spinal cord (Table~12)» Furthermore, at 
the dose of 4 mg/kg, the concentration of total lipids was 
decreased significantly (P/O.OOl) in all the four regions of 
OIS when compared with the values of control (Table-13)' 
Interestingly, the phospholipids were unaltered at the dose-
level of 1 mg/kg body weight (Table-14 ), but the increase of 
the dose to 2 mg/kg and 4 mg/kg, caused significant diminution 
of phospholipids in the cerebellum (P/O.05) and brain stem 
(P/0.05 and P/O.Ol respectively) (Table-15 and 16 ) • 
Statistically significant lowering of cholesterol was 
observed in all the regions of CNS at the dose of 1 mg/kg 
(Table- -^ 7). The maximum was in the cerebrum and brain stem 
(P/0.01). At the dose of 2 mg/kg (Table-18) it caused statis-
tically significant depletion in the cerebrum (P/0«00i), 
cerebellum (P/0.05), brain stem (P/O.OOl) and spinal cord 
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EXPLANATION OF •n-:E FIGURE 
Fig. 11 : Metasystox-Induced-Dose Dependent Depletion of total 
Lipid Levels in Different Regions of Rat Brain and 
Spinal Cord. 
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EXPLANATION OF THE FIGURE 
Fig. 12 : Metasystox-Induced Dose Dependent Depletion of 
Phospholipids Levels in Different Regions of 
Rat Brain and Spinal Cord. 
(3SV3aD3a iN3Da3d) 
SaidllOHdSOHd 
T5 
U 
O 
O 
c 
•H 
a 
CO 
c 
(0 
< 
> 
H 
o • 
o 
in 
o • 
o 
-1 
o • 
o 
tn 
o • 
o 
~-g \ l \ l -M 
ii:^ 
c 
•H 
m 
CQ 
CD 
Q 
PI 
O 
M-i 
00 
fM 
• 
1 
o 
• 
1 
« 
1 
• 
CO 
1 
^-
pa 
o 
0) 
c 
o 
•H 
O^  
<D 
(X 
•P 
C 
OJ 
Pi 
<U 
M-) 
M-i 
Q 
C 
•H 
O 
fH 
<U 
+J 
w 
O 
6 
O 
CD 
> 
(U 
- l 
<j; 
x: 
+j 
c 
•H 
in 
C 
O 
•H 
+J 
fD 
U 
Q) 
+> 
•H 
Q 
o 
XI 
en 
\ 
en 
e 
o 
X 
tn 
tn 
(0 
-P 
0) 
o 
c 
o 
• H 
- P 
<T3 
tn 
•H 
C 
•H 
G 
< 
CD 
x: 
+ j 
C71 
C 
•H 
O 
r-H 
rH 
o 
< 
H 
m 
K-1 
c/7 
o 
M 
CI 
w 
03 
'vi-
^ 
• O 
+ 1 
CO 
in 
• 
'^ 
CM 
00 
r-
• 
o 
+1 
o 
CM 
• 
H 
Cvj 
in 
to 
• 
o 
+ 1 
o 
no 
• in 
CNJ 
vO 
vO 
• 
o 
+ 
00 
H 
• 
r-CO 
r-
^ 
* 
H 
+ 1 
o 
h-
• 
o OJ 
•H 
vO 
• 
o 
+1 
H 
H 
• 
' t CM 
VO 
O 
• 
o 
+1 
"vt-
co 
• 
H 
00 
r-
in 
• 
H 
+ 11 
CM 
H 
• 
oo 
\r 
u Q) 
x: 
a. tn 
nH 
6 (D 
x: 
-H 
fO 
u X3 
CU 
M 
Q) 
O 
e 3 
rH 
-H 
CD 
X5 
OJ 
fH 
CU 
o 
e CD 
-P 
tn 
c 
•H 
fO 
h 
m 
•o M 
o 
o 
H 
fO 
c: 
•H 
a tn 
CO 
+ 1 
c 
e 
tn 
tn 
•H 
-P 
x; 
tn 
<u 
Pi 
^-l 
en 
S 
tn 
03 
-o 
if) 
Q) 
U 
a 
X 
0) 
tn 
CD 
o 
r-i 
03 
> 
113 
CO 
^ 
1 
(JJ 
H-J 
CO 
< 
H 
C 
•H 
a 
en 
-D 
C (T5 
c 
u 
19 f t : 
0) 
4-1 
o 
w 
c 
o 
0) 
cc 
-p 
c (U 
u 
<v H-i 
-^| 
•H 
Q 
c 
•H 
rH 
O 
0) 
• p 
•H 
O 
x: 
o 
^H 
O 
0) 
rH 
0) 
> O 
K 4 
cu 
J= 
• p 
c 
•H 
W 
c 
o 
• r l 
+> 
0) 
-P 
•H 
< 
• 
>-
m Q 
O 
H 
U 
O 
>-
•H 
(0 
Q 
-p 
5 
>' 
-o O 
j a 
cy> 
cy> 
e 
CM 
•«_>• 
X 
o 
- p 
>-if) 
to 
-P 
<u S 
I H 
o 
c 
o 
•H 
-P 
(0 
^1 
•p 
0) 
•H 
C 
•H 
E 
-o 
< 
o 
X 
4-> 
O i 
c 
•H 5 O 
f H 
f H 
O 
UH 
-o 
u 
o 
o 
D 
> 
a 
o 
< 
w 
X 
w 
s 
§ 
§ 
H 
CD 
M 
DQ 
•H 
8 
• O 
- ^ 
o 
• 
o 
\ | 
•H 
o 
o 
• 
o 
\ J 
• H 
o 
• 
o 
\ 
'sf 
r--
• 
o rg 
i n 
lO 
• 
^ 
H 
O 
Si-
• CM 
CNJ 
H 
h-
« CO 
H 
t^ 
vO 
* H 
+ 1 
^ 
LO 
• 
ro CM 
O^ 
\n 
• 
o 
+1 
o 
vO 
* 
o CM 
CO 
lO 
• 
o 
+1 
o 
ro 
• 
-sf 
C\j 
o Ch 
• 
o 
+1 
lO 
o 
• 
lO 
n 
r-
^ 
• 
-H 
+ 1 
o 
r-
« 
o CM 
H 
\ 0 
• 
o 
+1 
-H 
H 
• 
-vi-
CM 
vO 
o\ 
• O 
+1 
'^ 
fO 
• H 
ro 
t^ 
LO 
• H 
+ 1 
CvJ 
• H 
• CO 
"^  
<u 
u Q) 
x: 
a. U) 
•H 
e 
cu £ 
rH 
m 
^1 
^ 0) 
h Q) 
o 
s D 
M 
rH 
Q) 
Xi 
cu M 
Q> 
u 
e 0) 
-p (!) 
c 
•H 
ro JH 
CQ 
T5 
(H 
O 
O 
i H 
m C 
•H 
a in 
to 
4-1 
c 
fO 
CD 
E 
CD 
en 
in 
•H 
-P 
x: 
If) 
CD 
^1 
H^ 
cn 
\ . 
cr> 
E 
tn 
to 
- O 
CD 
in 
0) 
a 
X 
CD 
in 
CD 
3 
rH 
> 
]14 
. H 
fD 
c 
•H 
a U) 
-o 
c to 
c 
•H 
fD 
^1 
PQ 
H-> 
fO 
tf 
0) 
-P 
m 
o 
U) 
c 
o 
•H 
o p H <^  (X 1 
+J 
tu c 
H-1 <U 
03 U 
< a> 
H 4-1 
M-4 
•H 
Q 
C 
•H 
.H 
O 
H^ 
Q) 
H-" 
CO 
<U 
rH 
o 
x: 
o 
M-i 
O 
U) 
rH 
o 
> Q) 
K-1 
O 
x: 
•p 
c 
•H 
to 
C 
O 
•H 
-P 
03 
u 0} 
+> 
rH 
< 
• 05 
>-(0 
Q 
O 
H 
^ O 
M-4 
>-
^ 
•H 
fO 
Q 
-—^  
-P 
5 
>< 
-o 
o j a 
en 
^ \ 
en S 
sr 
X 
0 
-p 
If) 
>• 0) 
fO 
•p 
0) 
s 
<4-4 
o 
c 
o 
•H 
-P 
03 
u 
•p 
0) 
•H 
C 
•H 
e 
-a 
< 
CD 
x: 
+> 
en 
c 
•H 
5 
o M 
rH 
O 
u. 
-a h 
o 
o 
D 
< 
> 
a 
tu 
r-1 
s 
g 
H 
w 
PQ 
H 
8 
• o 
\ l 
o 
• o 
\ J 
H 
o 
o 
• o 
^ 
H 
8 
• o 
\ J 
OJ 
I.N 
• 
vO 
CM 
O 
t--
• h-
-H 
•H 
00 
• 0") 
CO 
o 
t^ 
• H 
CM 
^ 
\i) 
» o 
+ 1 
H 
O 
• H 
CM 
If) 
sf 
• O 
+ 1 
CM 
(X) 
• O 
H 
^ 
t^ 
• H 
+ 1 
00 
CO 
• o CM 
O 
•<t 
• H 
+1 
CM 
t -
• O 
ro 
h-
•st-
• H 
+ 1 
o 
• 
o CM 
-< 
vO 
• o 
+1 
-H 
-H 
• 
^ CM 
vO 
O 
• o 
+1 
s 
• 
•H 
00 
t^ 
lO 
• 
r-\ 
+1 
CM 
- H 
« 00 
sr 
<u fH 
(1) 
x: 
a 
w 
•H 
e 
o 
J C 
H 
03 
u 
X I 
<3J 
f^  
a; O 
e D 
rH 
rH 
0) 
X! 
OJ 
(H 
<U 
o 
s a; H-> 
U) 
C 
•H 
03 
^ 
m 
T5 
^ O 
O 
rH 
03 
C 
•H 
a to 
If) 
+1 
c 
03 
e 
a; 
10 
03 
•H 
•P 
x: 
0) 
Q) 
fH 
<4-l 
cn 
e 
03 
03 
03 
03 
CU 
U 
CL 
X 
CU 
03 
03 
D 
rH 
03 
> 
EXPLANATION OF THE FIGURE 
Fig. 13 : Metasystox-Induced Dose Dependent Depletion of 
Cholesterol Levels in Different Regions of Rat 
Brain and Spinal Cord. 
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(P/O.Ol). However at the dose of 4 mg/kg (Table-19/, the 
level of cholesterol depleted more significantly in cerebrum, 
brain stem, spinal cord (P/O.OOi) and cerebellum (P/O.Ol). 
Interestingly, after the administration of three different 
doeses (1,2 and 4 mg/kg body weight) of metasystox, cholesterol 
and phospholipid (C/P) ratio (Table-20, 21 and 22) was signi-
ficantly depleted in cerebrum, brain stem and spinal cord. 
Data presented in Table-23 reveal depleted levels of esterified 
fatty acids only in cerebral hemisphere (P/0«05) at the dose of 
1 rag/kg. However, esterified fatty acids were significantly 
decreased in cerebrum (P/0«00l), brain stem and spinal cord 
(P/O.05) at the dose of 2 rag/kg but cerebellum showed insigni-
ficant depletion (Table-24). Remarkable decrement in the level 
of esterified fatty acids at the dose of 4 mg/kg was discernable 
in cerebral hemisphere (-31.89%), brain stem (-25.18%) and 
spinal cord (-18.53%), but the cerebellum showed a decrease 
by only 6.92% (Table-25). Cerebral hemisphere exhibited 
insignificant depletion of ganglioside levels at the dose of 
1 mg/kg, while the content of gangliosides shwoed significant 
decrease in the cerebellum, brain stem and spinal cord (P/0.05) 
(Table-26), When the dose was increased (2 mg/kg) the concen-
tration of ganglioside was significantly decreased in cerebral 
hemisphere (P/O.Ol) and rest of the brain regions (P/O.OOl) 
(Table-27). Table-28 shows that the highest dose of metasystox 
(4 mg/kg) caused significant depletion in the level of 
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EXPLANATION OF THE FIGURE 
Fig. 14 : Metasystox~Induced Dose Dependent Depletion of 
Esterified Fatty Acids Levels in Different 
Regions of Rat Brain and Spinal Cord. 
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EXPLANATION OF THE FIGURE 
Fig. 15 : Metasystox-Induced Dose Dependent Depletion of 
Gangliosides Levels in Different Regions of Rat 
Brain and Spinal Cord. 
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gangliosides in all the brain regions and spinal cord (P/O.OOl). 
3.4.0 Histochenaical Study of Lipids After Metasystox Toxicosis 
As compared to the normal rats (Fig. 16), sections 
obtained from metasystox treated rats (Fig.i7)show less sudanophllic 
lipid deposits. Mild deposits of orange red reaction products 
of phospholipids at frequent places were seen in the experi-
mental section (Fig.19 ) as compared with normals (Fig.18 )• 
3»5«0 Effect of Three Different Doses of Metasystox (1.2 and 
4 mq/kq body weight) on the Rate of Lipid Peroxidation 
Rate of lipid peroxidation expressed as moles of malo-
naldehyde formed/30 minutes in different regions of the rat brain 
after the administration of three different doses of organo-
phosphate-metasystox is presented in Tables 29-31 • The rate 
of lipid peroxidation showed dose-dependent increase in all 
the regions of the CtiS (Fig. 20 )• At the dose of 1 mg/kg lipid 
peroxidation was significantly increased in cerebrum and 
cerebellum (P/O.05). However, no significant change was 
observed in the brain stem and spinal cord (Table-29). When 
the dose of metasystox was increased (2 mg/kg) the rate of 
lipid-peroxidation was also increased from 22.66% in cerebrum, 
28.37% in cerebellum, 23.59% in brain stem and 25.21% in spinal 
cord (Table-30). Furthermore, at the dose of 4 mg/kg, the 
rate of lipid peroxidation was increased significantly (P/O.OOl) 
Fig. 16 : Photomicrograph showing the total lipid contents 
(sudanophilic deposits) of cerebral hemisphere of 
control rat, Sudan black B, x 600. 
Fig. 17 : Photomicrograph of cerebral hemisphere showing the 
decrease in sudanophilic deposition of total lipids 
after the administration of metasystox, Sudan black 
B, X 600. 
Fig 16 
Fig 17 
Fig. 18 I Cerebral hemisphere of control rat showing 
the orange red reaction products of 
phospholipids, OTAN, x 600» 
Fig. 19 : Cerebral hemisphere of metasystox treated 
rat showing the diminution in the orange red 
reaction products of phospholipids. 
OTAN, X 600. 
Fig.18 
Fig.19 
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EXPLANATION OF THE FIGURE 
Fig. 20 : Metasystox-Induced Dose Dependent Elevation in 
the Rate of Lipid Peroxidation in Different 
Regions of Rat Brain and Spinal Cord« 
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in all the regions of brain and spinal cord when compared with 
the values of control (Table-3i). 
3*6»0 Effect of Metasystox (1,2 and 4 mq/kq body weight) on 
the Lipase Activity in Different Regions of Rat Brain 
and Spinal Cord 
The data embodied in Table 32-34 depict the results 
of metasystox (1,2 and 4 mg/kg body weight) administration to 
rats daily for 10 days* It caused dose-related elevation in 
the lipase activity (Fig.21 )• At the dose of 1 mg/kg, the 
lipase activity was significantly increased (P/0»05) only in 
the spinal cord but, statistically insignificant elevation was 
observed in rest of the brain regions (Table-32)» Interestingly, 
when the dose was increased to 2 mg/kg body weight the lipase 
activity was also raised significantly (P/^ O.OOi) in all the 
regions of CNS (Table-33)» Table-34 shows that the metasystox 
at the dose of 4 mg/kg produced maximum increase in all the 
regions of CNS (P/O.OOl). 
3.7.0 Histochemical Investigation of Lipase Activity 
Enzyme activity of metasystox-intoxicated rat cerebral 
hemisphere was found to be significantly increased showing 
well-marked deposition of brown-black precipitate (Fig. 23) 
when compared with the noraml control rats (Fig. 22). 
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EXPLANATION OF THE FIGURE 
Fig. 21 : Metasystox-Induced Dose Dependent Elevation in 
the Activity of Lipase in Different Regions of 
Rat Brain and Spinal Cord. 
* , ! ! w . v < i i - r - ^ ^ r a - f j ' j . • »«"$e#', j.JS,iyr •»%> j^' ^•<7—ggr-"^--'''^""^' 'i,^"'''i'^i''<j^^"T"»^ "t:a^"'g<"'^ - A "^atiaifr - -aa'a'**' •»•.-•¥' 
Fig. 22 : Photomicrograph showing lipase activity in the 
cerebrum of control rat ( x 300). 
Fig. 23 : Photomicrograph showing lipase activity in 
cerebrum of experimental rat (x300). 
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3.3.0 Effect of Vitamin E (150 I.U»/kq body weight. i.p» daily 
for 10 days) on the Rate of Lipid Peroxidation and Lipase 
Activity in Different Rpqions of Rat Brain and Spinal 
Cord Following the Administration of Metasystox (2 mq/kq 
body weight, i.p. daily for 10 days) 
Fig. 24 shows that the rate of lipid peroxidation signi-
ficantly increased in all the regions of brain and spinal cord 
(P/^O.OOl), but the administration of »C-tocopherol alone caused 
significant reduction of lipid peroxidation in the cerebral 
hemisphere, cerebellum, brain and spinal cord (P/O.OOi). When 
it was administered simultaneously with metasystox, e{^ -tocopherol 
prevented the metasystox-induced increase of lipid peroxidation. 
Interestingly the lipase activity was increased in the various 
regions of the Q^S after the administration of metasystox 2mg/kg 
body weight (P/O.OOi). However, the inhibition of lipase activity 
Was noticeable when ©(^ -tocopherol was administered in combination 
with metasystox in all the brain regions and spinal cord (P/O.OOi) 
as compared with the values of control (Fig. 25). 
3.9»0 Effect of Metasystox (1.2 and 4 mq/kq body weight, i.p. 
daily for 10 days) on the Levels of DMA and RNA 
The levels of DNA and RNA in different regions of the 
rat brain and spinal cord after the administration of various 
doses of metasystox are presented in Table 35-40 A dose-dependent 
diminution of ENA was observed (Fig. 2 6). At the dose of 1 mg/kg 
EXPLANATION OF THE FIGURE 
Fig. 24 : Effect of Vitamin E on the Rate of Lipid 
Peroxidation in Different Regions of Rat Brain 
and Spinal Cord Following the Administration 
of Metasystox (2 mg/kg body weight) values 
represent -f S.E. 

EXPLANATION OF THE FIGURE 
Fig. 25 : Effect of Vitamin E on the Lipase Activity 
in Different Regions of Rat Brain and Spinal 
Cord Follov/ing the Administration of Metasystox 
(2 mg/kg body weight) values represent mean ^ S.E 

\u 
the ENA level was significantly decreased from 26.94% in cerebral 
hemisphere, 14*81% in cerebellum, 20.00^ in brain stem and 
18*75% in spinal cord (Table-35)« Whereas the diminution was 
correspondingly more (P/O.OOl) at the dose of 2 mg/kg in all 
the regions of brain and spinal cord (Table~36), However, 
when the dose was increased to 4 mg/kg the percent decrease 
diminution was also raised from 69.94% in cerebrum, 41.58% in 
cerebellum, 56.00% in brain stem and 43.75% in spinal cord 
(Table-37). Results presented in Fig. 27. demonstrate regional 
heterogeneity in the concentration of RNA after the administra-
tion of metasystox. Table-38 shows that at the dose-level of 
1 mg/kg the concentration of RNA significantly (P/O.GS) 
diminished in the cerebrum, but the level of RNA increased in 
cerebellum (P/^0.05), brain stem (P/p.OOi) and spinal cord 
(P/p.Ol). At the dose of 2 mg/kg the diminution in the RNA 
content was observed in cerebrum (P/_O.Ol) but the RNA concen-
tration was increased in cerebellum, brain stem and spinal cord 
(P/0,00l) (Table-39). However, at the dose of 4 mg/kg(Table.40) 
the maximum lowering (-40.0^ ) of RNA content was detected in 
the cerebrum. The concentration of RNA was increased signi-
ficantly in cerebellum, brain stem and spinal cord (P/O.OOl). 
Dose-related alteration in the level of RNA is presented in 
Fig. 27. 
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EXPLANATION OF THE FIGURE 
Fiq. 26 : Effect of metasvstox (l, 2 and 4 mg/kg body weight 
i.p.daily for 10 days) on the level of DNA in 
different regions of rat brain and spinal cord. 
Values expressed as mg/g fresh tissue,' mean j^  S.E. 
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EXPLANATION OF THE FIGURE 
Fig. 27 : Effect of metasystox (l, 2 and 4 mg/kg body 
weight i.p» daily for 10 days) on the level of 
ENA in different regions of rat brain and spinal 
cord* Values expressed as mg/g fresh tissue, 
mean ^^^  S*E. 
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3»10.0 Histochemical Localization of Nucleic Acids 
Mild deposits of green and red reaction products of DNA 
and RNA were found in the experimental sections (Fig. 29) at 
frequent places, when compared with normals (Fig. 28). 
3.11.0 Effect of Metasystox (1.2 and 4 mq/kq body weight, i«p« 
daily for 10 days) on the Activity of DNase, RNase and 
Protein Content 
Results presented in Fig. 30 and 31 show the dose related 
effects of metasystox on the activity of Oslase and RNase in 
different regions of CNS. Table 41-43 depicts consistent 
elevation of the activity of ENase in the various areas of rat 
brain and spinal cord. nJase activity was significantly raised 
in cerebellum (P/0.05), brain stem (P/_0«Ol) and spinal cord 
(P/0.05) at the dose-level of 1 mg/kg body weight (Table-41). 
However, cerebrum exhibited insignificant elevation after the 
administration of metasystox (2 and 4 mg/kg). At the dose of 
2 mg/kg (Table-42), ENase activity significantly raised in 
cerebellum (P/0»05), brain stem (P/O.OOl) and spinal cord 
(P/O.OOl). The maximum elevation (Table-43) was detected at 
the dose of 4 mg/kg in rest of the regions (P/O.OOl). Statisti-
cally significant increase in the activity of RNase in the spinal 
cord was observed after the administration of metasystox at the 
dose level of 1 mg/kg body weight. RNase activity insignifi-
cantly elevated in the cerebellum and brain stem but it was 
Fig* 28 : Photomicrograph showing nucleic acids 
concentration of the cerebrum of control 
rat { x300). 
Fig. 29 : Photomicrograph showing diminition of nucleic 
acids concentration in the cerebrum of the 
metasystox treated rat ( x 300). 
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EXPLANATION OF THE FIGURE 
Fig. 30 : Effect of metasystox (l, 2 and 4 mg/kg body 
weight i«p« daily for 10 days) on the activity 
of DNase in different regions of rat brain and 
spinal cord Activity of DNase expressed as 
units/mg protein. Values expressed Mean + S.E. 
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insignificantly depleted in the cerebral hemisphere (Table-44). 
At the dose of 2 mg/kg, insignificant depletion in the activity 
of RNase was discernable in the cerebral hemisphere but 
cerebellum and spinal cord showed an increase by 16.70% and 
21.50^ respectively (Table-45). However, the increase of the 
dose to 4 mg/kg body weight caused significant (P/,0.05) diminu-
tion of Rlslase activity in the cerebrum, but it was significantly 
elevated in cerebellum (P/O.OCl), brain stem (P/O.Ol) and spinal 
cord (P/O.OOl) (Table-46). 
Interestingly, the protein contents were unaltered at 
the dose-levels of 1 and 2 mg/kg body weight in all the regions 
(Table-47 and 48) but the increase of the dose to 4 mg/kg body 
weight caused significant diminution of protein level in 
cerebellum and spinal cord (P/0.05) (Table-49). Fig. 32 
represents dose-dependent alterations in the protein content. 
ANOVA (Table-50 to 61) revealed that the total variation 
within different regions of the brain is significant, which is 
an evidence of the heterogeniety of the brain. On the other 
hand variation due to the effect of different doses of metasystox 
in the regional lipid and nucleic acid profiles is also signi-
ficant. 
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EXPLANATION OF THE FIGURE 
Fig. 31 : Effect of metasystox (1,'2 and 4 mg/kg body 
weight i.p. daily for 10 days) on the activity 
of RNase in different regions of rat brain and 
spinal cord Activity of RNase expressed as units/mg 
protein. Values represent Mean 4; S.E. 
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EXPLANATION OF THE FIGURE 
Fig. 32 : Effect of metasystox (1, 2 and 4 mg/kg body 
weight i»p» daily for 10 days) on the level 
of protein in different regions of rat brain 
and spinal cord. Values expressed as mg/g 
fresh tissue. 
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4.0 DISCUSSION 
Studies on the concomitant inhibition of cholinesterases 
caused by organophosphorus compounds has been described in 
considerable details but less attention has been given to 
distrubances of lipid and nucleic acid metabolism. This aspect 
seems worthy of further investigation, since the organophosphorus 
compounds have been referred to as 'myelin poisons* and lipids are 
the essential components of all the cellular structures of brain. 
In the present study organophosphate metasystox influenced the 
lipid and nucleic acid metabolism in the brain. The results 
indicate that metasystox administration causes dose-related 
depletion of the total lipids, phospholipids, cholesterol, 
esterified fatty acids and gangliosides in the various regions 
of the rat central nervous system. This stands to reason on 
account of the dose-dependent increment in the rate of lipid 
peroxidation and lipase activity in the same regions of the CNS. 
Estimations of nucleic acids demonstrate the regional hetero-
geneity not only related to the effects of metasystox on the 
concentration of nucleic acids, protein and enzymes but also in 
their levels in different regions of rat brain. Furthermore, 
administration of a^-tocopherol alone caused significant reduction 
of the rate of lipid peroxidation and lipase activity, and in 
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combination with metasystox, prevented the increase of lipid 
peroxidation and lipase activity. No comparable results of 
any previous study dealing with this subject are available in 
literature (Medlars, citation, 1985). The possibility, that 
metasystox an organophosphate might be playing some role in 
affecting the lipid and nucleic acid constituents differentially 
in the various regions of the brain remains open. 
4.'10 Metasvstox-Induced Toxicosis in the Different Regions of 
the Rat Brain Lipids 
Lipids account for half the dry weight and most of the 
structural architecture of membranes in the brain (Ordy and 
Kaack, 1975). Myelin sheath and neuropil of grey matter account 
for much of the total lipids contents of brain tissue (Scharf, 
1953, and Schimizu, 1965). They make up about 65% of the dry 
weight of the white matter and 35-40% of grey matter (Brante, 
1949). The important lipids of the central nervous system 
are cerebrosides, phospholipids, cholesterol, fatty acids and 
sphingomyelin. It is well known that distinct regional 
differences occur in lipid content and turnover in cell types 
and various pathways and centres of the raammlian brain. Changes 
in the content of lipids and lipid composition must be due to 
the changes in rates of anabolism, catabolism, or both. These 
processes are regulated by the activities of appropriate 
enzymes, ^t might be expected that in adult animals, brain 
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lipid metabolism takes place mainly in compartment of the central 
nervous system (Davison et al., 1958)• Destruction of the myelin 
lipid by various means inevitably leads to neurological dysfunction 
in man and animals-
The importance of phospholipids of central nervous system, 
presumably dependent upon their role as membrane constituents. 
The phospholipids of myelin are largely stable throughout the 
lifespan of the animal (Davison and Dobbing, I960). In the 
membranous structure of microsoms are located a large number of 
enzymes responsible for phospholipid synthesis. The properties 
of a membrane will be governed to some extent by its composition 
and since this is partly phospholipid in nature, the effect of 
drugs on phospholipid metabolism is of great importance. Occa-
sional results have indicated that phosphotidyl choline may be 
transferred intact from the blood to the brain (Hoelzl and 
Franck 1969; Ansell and Spanner, 1971). It was observed that 
phospholipid may reach the site of action at the cellular level 
as intact molecules. 
The high concentration of cholesterol seems to be charac-
teristic of nervous tissue. The constancy of the amount of 
cholesterol in the brain suggests that the sterol is metabo-
lically stable and is thus removed from the normal dynamic 
exchange process common to almost all ©ther body constituents 
(Waelsch et al., 1940). Studies in cell layers of monkey cerebral 
I8:i 
cortex have shovm that the distribution of cholesterol is almost 
a mirror image of that of the protein, cholesterol increases and 
protein decreases, with increasing cortical depth (Robins et al., 
1956). 
Sinclar (1956) concluded that progressive deficiency of 
essential fatty acids in the diet was one of the factors involved 
in demyelinating diseases of nervous system. Studies using radio 
active isotopes indicate that both lipid fatty acids and phospho-
lipids,' respectively are raetabolically more active than choles-
terol, both in adult and young brains (Waelsch et al», 1940, 
and Dawson, 1955). 
Gangliosides are synthesized in neuronal parikarya and 
transported to nerve endings togather with macromolecules 
(Rahmann and Rosnek, 1973), but local synthesis within the axon 
and nerve endings (Leden et al., 1976b) or even at the plasma 
membrane level (Preti et al., 1980) can not be excluded. They 
are involved in the nerve impulse conduction since they act as 
receptor sites for neurotoxins (Van Heyningen, 1959 and North 
et al., 1961). According to Iiwin and Samson (l97l), certain 
types of behavioural stimulation seem to be accompanied by 
alteration of ganglioside metabolism, compared to corresponding 
control animals. 
In the present study, following the administration of 
metasystox in three doses (1,2 and 4 mg/kg body weight), levels 
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©f total lipids,' phospholipids, cholesterol, esterified fatty-
acids and gangliosides were determined in cerebral hemisphere,' 
cerebellum, brain stem and spinal cord. Results indicate that 
metasystox administration causes significant dose-related 
depletion of the total lipids in various regions of the central 
nervous system. To date, no report is available on the quanti-
tative estimation of various lipid fractions in different 
regions of the rat brain following metasystox intoxication. A 
report on the effect of three potent anticholinesterases con-
taining phosphorus, diisopropylflurophosphonate (DEP), triortho 
cresylphosphate (TOCP) and bismonoisopropylaminoflurophosphine 
oxide (Mipafox) indicates that anticholinesterases affect lipid 
metabolism in the nervous system (Majno and Karnovsky, 1961). 
There may be no relationship between the anticholinsterase 
activity of these organophosphorus compounds and the effects on 
lipid metabolism (Davies and Austin, 1953). In another study, 
Majno and Karnovsky (1955) showed that Mipafox inhibited the 
uptake of C acetate into nerve lipids in vitro by 50%; later 
(Majno and Karnovsky, 1961) they carried out an extensive 
investigation on the effect of Mipafox on lipid biosynthesis 
in nervous tissue and concluded that this substance acted on 
the nerve cell perikaryon, since both axon and sheath degene-
rated simultaneously. The effects were not dissimilar to 
Wallerion degeneration and a primary central lesion was indicated. 
In the present report, organophosphate-metasystox at the 
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dose of 4 mg/kg body weight inhibited the phospholipid metabolism 
in the brain. These observations can very well be explained on 
the basis of the findings of Nelson and Barnum (i960) who 
reported an effect on brain phosphatidylcholine metabolism, 
occurring a very short time after the injection on 2.5 mg/kg 
32 body weight of DFP. Transfer of p from the acid-soluble pool 
to the phospholipids was significantly reduced by determining 
the specific radioactivities of the phospharylcholine and the 
phosphotidylcholine at three different times after injection of-
32 p orthophosphate. They concluded that there was a reduction 
in the rate of transfer of phosphorylcholine to phosphotidyl-
choline by Kennedy pathway (Fig.sl). It is likely that the 
reduction in the rate of transfer of phosphorylcholine was a 
genuine one. This inhibition of phospholipid biosynthesis at 
a point subsequent to the phosphorylation of the base is a 
feature exhibited by some other drugs that inhibit phospholipid 
metabolism. 
Dobbing (1964) showed that cholesterol accounts for 
18-20% of the dry weight of the myelin fraction and about 70^ 
of the total brain cholesterol is present in the myelin as in 
index of myelination. Although the sterols of normal adult 
brain a re accounted for almost exclusively by free cholesterol, 
demyelination as a result, for example, of organophosphorus 
intoxication or multiple sclerosis leads to a loss of choles-
terol and the short-lived appearance of cholesterol esters 
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(Davison and Wajda, 1962). There is no evidence that organo-
phosphate Mipafox is a "specific myelin poison" (Majno 8. 
Karnovsky, 1961) • However, in the experiments to test the 
effect of Mipafox on lipid biosynthesis, the aforementioned 
investigations showed that Mipafox does inhibit the incorpo-
ration of acetate,choline and phosphate into the lipids of 
nervous tissue. In the present study, organophosphate 
metasystox also depleted the levels of total lipid, phospho-
lipids, cholesterol in different regions of brain. It can be 
assumed that a similar mechanism may be at play here too. 
Cholesterol and phospholipid ratio is generally considered 
to be an index of atherogenecity. Cholesterol appears to be 
incorporated into the cells of lessions, esterified within the 
cell and transformed into amorphous droplets of cholesteryl 
esters (Weller et al., 1968). The accumulation of cholesterol 
in aorta parallels remarkably well with the serum cholesterol 
(Nicholas et al., 1971). Furthermore, the presence of lecithin-
cholesterol transcyclase in the arterial wall provides evidence 
for the esterification of cholesterol in aorta, since only free 
cholesterol rather than esterified cholesterol is exchanged with 
the blood during atherosclerosis. It was noted during this 
study that C/P ratio was depleted in all the regions of brain 
following metasystox toxicosis. The exact mechanism by which 
C/P ratio in the tissues and tissue fluids of the discrete 
brain regions is regulated, is obscure. However, fatty acids 
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in the central nervous system can arise by synthesis'in situ' 
and by transport from the blood stream. Thus the passage from 
blood to the brain is not prevented by blood brain-barrier 
system (D' Amado, 1970). Recent studies have indicated that 
both possibilities exist (Dhopheshwarkar and Mead, 1970). The 
net break-down of protein in a given tissue depends upon the 
supply of alternative (non-protein) substrates to that tissue, 
such as fatty acid and glucose (Goldberg and John, 1976). A 
decreased rate of utilization of plasma free fatty acid may 
involve changes in the rate of esterification or of oxidation 
of fatty acids (Cunningham, 1977). As early as 1956, Sinclair 
concluded that progressive deficiency of essential fatty acids 
in the diet was one of the factors involved in demyelinating 
diseases of the central nervous system. In the present study 
it appears that metasystox affects the esterified fatty acid 
levels in all the regions of central nervous system. 
Gangliosides, sialic acid containing glycosphingolipids, 
are embedded in neural plasma membranes to provide cell surface 
recognition sites (Ando, 1983). They may not be evenly distri-
buted on the cell surface, but exist rather in clusters surroun-
ding membrane bound proteins as a functional aggregate (Sharom 
and Grant, 1978; Yamakawa and Nagai, 1978; Lee and Grant, 1980). 
It is now generally assumed that exogenous ligands such as 
bacterial toxins, antigens, calcium ion and so on bind to 
specific gangliosides to induce sequential activations of 
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membrane associated enzyme reactions and cellular metabolism 
(Yamakawa and Nagai, 1978; Hakomori, 1981). Furthermore, 
Rahmann (1982) has speculated that •gangliosides play some role 
in synaptic transmission. Ramsey and Nicholas (1972) have 
indicated that the binding of serotonin to synaptic vesicles 
may be mediated by gangliosides. It is also of interest to 
note that certain types of behavioural stimulations (stress, 
excercise, sensory stimulation, learning) seem to be accompanied 
by alteration of ganglioside metabolism, compared to corresponding 
control rats (Irwin and Samson, 1971). In the present study, the 
depletion in the ganglioside levels can be explained on the basis 
of the recent findings of Islam et al. (1983), who have observed 
reduction in the gangliosides concentration in different regions 
of brain and spinal cord following the administration of organo-
phosphate. There is no previous report on the levels of 
ganglioside in various regions of CNS following the adminis-
tration of different doses of metasystox. Whatever may be the 
specific role or roles of gangliosides in the brain, it is 
clearly evident by now that they serve an active rather than 
passive function. 
In general it can be inferred that metasystox adminis-
tration causes dose-related depletion of total lipids, phos-
pholipids, cholesterol, esterified fatty acids and gangliosides 
in the various regions of the central nervous system. The 
depletion of the content of various lipid levels might be due 
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to the fact that peroxidation of endogeneous lipids has been 
enhanced by organophosphate metasystox. The present findings 
are also in accordance with the dose-dependent increase in the 
activity of lipase in the same regions of the central nervous 
system. These observations support the already reported 
(Islam et al., 1983) elevation of lipid peroxidation and lipase 
activity by metasystox. Recently, Haider et al. (1982) from 
this laboratory have also reported that the increment in the 
brain lipid peroxidation contributes to the decrement in the 
brain lipids. Further studies aimed at the evaluation of 
relevent enzymes are underway and it is hoped that a better 
insight may be obtained pertaining to possible mechanisms of 
organophosphate metasystox-induced alterations in the lipid 
metabolism. Hence the reduction of different lipid levels, 
irrespective of their regional variation may be due to the 
increased rate of degradation, as is obvious from the present 
findings of increased lipase activity which is likely to enhance 
the rate of degradation of lipids, resulting in the lowering of 
the lipid concentration. 
4,2»0 Metasystox-.rnduced Elevation in the Rate of Lipid Peroxidation 
Lipid peroxidation, being the basic mechanism of distruction 
of unsaturated fatty acid chains in biological membranes, is 
maintained in the organism on a required level by a combination 
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of several controlling factors. The peroxidation of endogeneous 
phospholipids in biological membranes has long been thought to 
be the basis for a variety of toxicological phenomena . For 
example, lipid peroxidation has been implicated in the damage 
to cells that results from their exposure to air pollutants, 
chlorinated hydrocarbons, oxydent hemolytic agents, ethanols, 
and even organophosphates. Lipid peroxidation appears to be 
a phenomenon that reflects free radical events associated with 
biological membranes, which contain most of the polyunsaturated 
fatty acid-containing lipids in animal tissues. The brain 
homogenate has apparently the necessary unsaturated fatty acids 
and the catalysts for peroxidation in the architecture of the 
cell itself which are readily available for reaction with 
molecular oxygen to undergo lipid peroxidation. Peroxidation 
involves the direct reaction of oxygen and lipid to form free 
radical intermediates and to produce semistable peroxides. 
The nature of the primary free radicals generated in living 
cells and able to initiate lipid peroxidations remains one of 
the most challenging problems. Three types of the radicals 
may be considered as possible candidates for this function: 
(l) semiquinons participating in electron transport in respira-
tory chains of mitochondria and hydroxylation systems in liver 
endoplasmic reticulum, (2) organic molecular free radicals 
produced in reactions initiated by irradiation of the biological 
system by U.V. radiation or during autooxidation of some 
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substances by molecular oxygen, and (3) free radicals created 
by sequential addition of electrons to oxygen molecule 0~ and OH. 
In spite of the close correlation observed between lipo-
peroxidation activity and free radical level in tissues, direct 
evidence for the relationship between metabolic (semiquinone) 
free radicals and those responsible for initiating the lipo- . 
peroxidation process has not yet been obtained (Burlakava et al., 
1975). Not much information is available on possible initiation 
of the lipoperoxidation process by organic molecule free radicals 
in biological systems• The "active form of oxygen" have become 
a matter of growing interest to researchers. To some extent 
this may be attributed to the development of new methods both 
to detect the very presence of active oxygen molecules (02» ^2 
and OH) and as hydroxylation of unnatural compounds, lipid 
peroxidation, and cell injury phenomena (cf. Merzljak and 
Sobolev, 1975; Fridovich, 1974a,b; Beveris et al., 1972; 
Rosenthal, 1976; Hamberg et al., 1974). 
* _ 
Superoxide radical O"; may undergo oxidation to final 
stable products (Vladimirov et al,, 1970) or, alternatively, 
initiate lipid peroxidation, if unsaturated fatty acids are 
available in the vicinity. In fact superoxide radicals never 
exist alone in water solution but spontaneously create all forms 
of "active oxygen" in the sequence of reactions (Merzljak and 
Sobolev, 1973). 
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Many reactions of auto-oxidation of biochemical substrates 
are shown to generate superoxide radicals and hence all forms 
of "active oxygen". The effect of sulfuroxides on living 
organisms in an experimental model have shown that sulfite 
oxidation is remarkably accelerated by superoxide anion radical 
(O2) and Mn , suggesting sulfite radical formation in oxidation 
process (Inov ye et al., 1978). It is also known that sulfite 
accelerates lipid peroxidation in vitro. Lizada and Young (1981) 
have shown that sulfite can cause peroxidation of PUFA via a 
free radical mechanism. These observations suggest that 
metasystox a sulfur containing organophosphorus compound may 
iiaflict biological damage in vivo by initiating peroxidation 
of PUFA, particularly in membranes. Recent studies (Haider 
et al., 1980, 1981)»have revealed that exposure of guinea pigs 
and rats to air pollutants S0„ and HpS induced significant 
increase in the rate of lipid peroxidation. 
The induction of massive accumulation of cytoplasmic 
dense bodies (lipofuscin pigment) has been shown following 
organophosphate pesticide-dichlorvos toxicosis (Hasan et al., 
1979, and Hasan and Ali, 1981). The increased incidence of 
electron dense bodies appears to be the end result of lipid 
peroxidation. The possibility that lipid peroxidation may 
be a basic mechanism of toxicity of wide variety of environ-
mental chemicals has made this phenomenon a focus of toxicologic 
interest. 
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The similarity of peroxidation end product to the electron 
dense pigment granules has been verified by Chio and Tappel 
(1969) on the basis that lipid peroxidation of subcellular 
organellae gives fluorescenet products which have characteristic 
spectra with a maximum of 470 nm when excited at 360 nm, similar 
to that of lipofuscin pigment. 
Spoerri and Glees (1979) have reported similar increase 
of electron dense bodies, labelled by them as lipofuscin, 
following intoxication with another organophosphate compound 
TOCP (Triorthocresyl phosphate) in the hen. Recently from this 
laboratory Hasan and Ali (1981) have reported organophosphate 
dichloryos -induced dose-dependent increase in the rate of lipid 
peroxidation* Increment in the brain lipid peroxidation also 
contributes to the decrement in the level of the brain lipids 
(Tayyaba and Hasan 1985). In the present investigation, 
malonaldialdehyde formed due to metasystox-intoxication was 
increased significantly in different regions of the brain and 
spinal cord. It is clear that the peroxidation of endogeneous 
lipids was enhanced by metasystox administration and thus 
resulted into degradation of various lipid levels in different 
brain regions. 
4.3.0 Metasystox-Induced Elevation of Lipase Activity 
The results indicate that metasystox administration causes 
significant dose-related elevation of lipase activity in different 
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regions of the rat brain and spinal cord- No report on the 
dose-dependent effect of organophosphate metasystox on the 
activity of lipase in various regions pf CNS is available in 
the literature. However, Thompson (1964) has described phospho-
lipase 'A' and 'B' activity in the brain. In the brain, lipase 
activity is concentrated more in grey matter than in the white 
(Gozzano, 1934). Among different brain regions, human cerebral 
cortex has the highest phospholipase 'A' activity. Triglycerols 
and diacylglycerols of mammalian brain are very active metabo-
lically and are hydrolyzed by lipases (Mizobuchic et al., 1981; 
Vyvoda and Rowe, 1973). Rates of lipase reaction can therefore 
be measured by determining either the rate of disappearance of 
the substrate or the rate of production of the fatty acids. 
Shull and Cheeke (l973) found that there was a tendency 
for triorthocresyl phosphate (TOCP) to increase the specific 
activity of lipase in pancreatic homogenates. However, it is 
of interest to note that tissue lipases are activated by 
phosphate (Yakovlev, 1950). Beauchamp and Fridovich (1970) 
suggested that an oxidizing species, the hydroxyl radical (OH), 
is generated in the presence of O2 and H202. Hydroxyl radical 
could react with plasmalemmal membrane initiating chain 
reactions which would result in the generation of lipid 
peroxide radicals, lipid hydroperoxides and fragmentation 
reaction products such as malonaldialdehyde (Maestro et al., 
1980). Membranes phospholipase A^ activity could be enhanced 
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by OH which would result in archidonic acid release and the 
generation of various endoperoxide metabolites (Pryor and 
Stanley, 1975; Kuhel et al., 1977, 1979). Recently Haider et al. 
(1981) have reported that the decreased concentration of lipids 
in cerebrum, cerebellum and brain stem may be due to increased 
activity of lipase in these regions. The evidence for free 
radical mechanisms in the asymmetric loss of polyunsaturates 
from membrane phospholipids leaving saturates almost intact, at 
time periods that far beyond the temporary activation of phospho-
lipase A seen in rat decapitation experiments (Demopoulos et al., 
1980). 
The increased lipase activity may help in faster trans-
location of lipids,' thus creating a lipid defeciency (Jos and 
Obden, 1979). Such situation can affect the functional integrity 
of cytomembranes, leading to disturbances in lipid composition 
of neuronal and glial membrane. Furthermore, an increased lipase 
activity in various regions of the brain induced by metasystox 
is likely to trigger enzymatic and non-enzymatic lipid peroxi-
dation, which in turn may lead to manupulation to cellular 
injury. On the basis of the aforementioned explanations it 
can be concluded that metasystox generated free-radical in 
brain and thereby elevated lipid peroxidation and lipase 
activity. 
i% 
4.4.0 Effect of Vitamin E on the Rate of Lipid Peroxidation and 
Lipase Activity Following the Administration of Metasvstox 
The identification of vitamin E as a fat-soluble vitamin, 
its occurrance in vegetable oils, its storage in association 
with body lipids and its possible function as a biological 
antioxident suggest that a close relationship exists between 
vitamin E and various phases of lipid metabolism. As with the 
unsaturated fats, organophosphates may catalyze the formation of 
an oxidative state in brain lipids creating a greater need for 
vitamin E (Hove, 1953, Hove, 1955). The antivitamin E activity 
of organophosphates has been questioned (Green and Bynyan, 1969; 
Myers and Mulder, 1953; Cawlishaw and Blaxter, 1955; Goyer et al., 
1970). Some have proposed that organophosphate tri-ortho-cresyl 
phosphate (TOCP) merely reduces the absorption of vitamin E from 
intestinal tract, thereby accounting for the lowered blood level 
of vitamin E characteristic of TOCP poisoning (Myers and Mulder, 
1953). Findings of Shull and Cheeke (1973) indicate that the 
administration of TOCP may influence the utilization of vitamin E. 
In growing rats, supplementation with vitamin E prevented the 
growth cessation caused by feeding TOCP (Shull and Cheeke, 1973). 
Similarly, in the present study, rats that had ceased growing 
following metasystox administration responded with renewed growth 
and significant weight gain when vitamin E was administered-
After the pioneering works of Kurdrjashov (1937) and Davies 
and Moore (1941), an appreciable number of scientists have been 
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investigating the relationship between vitamin E and lipid 
peroxidation, in particular, the contribution of Tappel's 
laboratory has generally been recognised (cf• reviews Tappel, 
1962, 1972, 1973; Vladimirov and Archakov, 1972). 
The role of vitamin E as a biological antioxidant and its 
interrelationships with some phases of lipid metabolism, point 
to a possible involvement in certain enzyme systems in the body. 
It has been suggested that the clinical manifestations of 
vitamin E deficiency result from the action of lipid peroxides 
on sulfhydryl groups of various enzyme systems, thus inhibiting 
their activity. The significant increase of lipase activity in 
the TOCP-fed rats may reflect an effect on lipase synthesis 
(Shull and Cheeke, 1973). There was a slight tendency for 
vitamin E to reduce the specific activity of lipase in the 
pancreatic homogenates (Shull and Cheeke, 1973). Recent studies 
(Tayyaba and Hasan, 1985) revealed that the increase of lipase 
activity, which occurs after metasystox intoxication, was 
remarkably reversed by^-tocopherol. In the present study the 
reduction in the activity of lipase in the various regions of 
CNS in the vitamin E supplemented rats can be explained on the 
basis of the afore-mentioned observations. 
A significant body of evidence indicates that the primary, 
if not the sole, function of vitamin E in metabolism is that of 
an 'in vivo' lipid antioxidant. Probably the most direct evidence 
to substantiate this theory is that lipoperoxides have been found 
19^ 
ira the tissues of vitamin E-deficient animals (Dam and Granados, 
1945). It is assumed that vitamin E acts as an 'in vivo' lipid 
antioxidant, protecting unsaturated fatty acids in tissue lipids 
against peroxidation. 
The chemical process of peroxy free-radical reaction with 
an antioxidant (Vitamin E) to terminate the reaction chain is 
defined as follows: 
LOO + Vitamin E LOOH + Vitamin E 
peroxy free Oxidized 
radical 
Bieri and Anderson (i960) suggested that each tissue had 
an "antioxigenic potential" which was determined by a balance 
between factors promoting peroxidation and by those exerting 
an antioxidant action. 
According to Combs et al. (1975) at least two systems are 
important for uncontrolled lipid peroxidation. These systems 
rely on selenium and vitamin E, respectively, and form the basis 
for the hypotheses concerning the antioxidant functions of 
these nutrients (Combs et al., 1975). Hoekstra (1975) has shown 
that the organophosphate, tri-o-cresylphosphate, interferes with 
selenium and glutathion peroxides. It appears likely that a 
similar mechanism operates in the metasystox-induced increase 
in the rate of lipid peroxidation observed in the present study. 
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The peroxidative changes triggered by free radicals in 
brain fatty acids and phospholipids may be of importance in 
the development of brain cell damage. Free radical, i.e. highly 
reactive molecules with an unpaired electron in an outer orbital, 
are constantly being formed in various reactions essential for 
aerobic life. The best studied effect of free-radical attack 
is that causing lipid-peroxidation i.e, oxidation ofKmethylene 
bridges of unsaturated fatty acids, resulting in the formation 
of lipid peroxides and hydroperoxides, finally leading to 
fragmentation of lipids. As biomembranes are rich in unsaturated 
fatty acids, such reactions may lead to the disintegration of 
membrane structure and finally to irreversible cell damage. 
Vitamin E (=<tocopherol) is known to stabilize plasma membranes 
(Porta et al., 1968) as well as lysosomal membranes (Brown and 
Pollocle, 1972) and also mitochondrial membranes(Frigg and Rohr 
1976). In the present study the administration of «?(-tocopherol 
alone caused significant reduction of the rate of lipid per-
oxidation, and in combination with metasystox, prevented the 
increase of lipid peroxidation. Thus,it is not unreasonable 
to postulate that the protective effect of c(.-tocopherol is 
effected by its free-radical scavenging, antioxidative and 
membrane stabilizing effects. 
4.5.0 Metasystox-Induced Toxicosis Reflected in the Levels of 
Deoxyribonucleic acid (PNA) Concentration and the Activity 
of Deoxyribonuclease (ENase) in Different Regions of the 
Rat Brain and Spinal Cord 
Following metasystox-intoxication, levels of DNA and the 
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activity of DNase were determined in different regions of the 
rat brain and spinal cord. Levels of UNA were decreased sig-
nificantly in all the regions of the brain- However, activity 
of ENase exhibited increment in different brain areas. Data 
in the literature on the action of organophosphates indicate 
that these compounds can induce DNA damage and mutation in 
bacteria and lower eukaryotes (Green et al., 1974; Griffin and 
Hill, 1978; Wild, 1975) and that they posses weak methylating 
activity (Green et al., 1974; Lawley and Shah, 1974; Lofroth 
and Wennerberg, 1974). Since the average amount of DNA per diploid 
nucleus is constant for all normal tissues of the body, including 
brain tissue (Heller and Eliott, 1954), measurements of EWA 
amounts provide a convenient method for estimating the total cell 
population in various regions of the brain, or in the entire 
brain (Friede, 1963). Furthermore, the measurement of E^A may 
also be useful in detecting whether toxic agents affect cellular 
proliferation and cell death during cerebral maturation. The 
studies of an organophosphate, phosalone, on rat brain reveal 
significant decrease of DNA level in various regions of the 
brain (Kirubagaran, 1984; Palanivelu, 1984; Tamilvanan, 1984). 
Paolo and Fini (1980) reported that organophosphate dichlorvos 
caused damage on DNA and the repair process. This was evidenced 
by the higher values obtained when the cells were cultured in 
the presence of the pesticide. 
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It has been shown that different regions of the brain have 
different ENA concentrations. The maximum concentration of ENA 
was observed in cerebellum (5.85 + O.l) which was almost 4 times 
of the next highest level determined in the cerebral hemisphere 
(1.93 + 0.33). Our finding are in agreement with the observations 
of May and Grenull (1959). Large total amounts of DNA in 
cerebellum reflect the extreme cell density of cerebellar granular 
layer. This observation finds support in the earlier reports of 
Tayyaba et al. (1981). Among the regions analysed, maximum 
depletion of EWA occurred in cerebral hemisphere (-69*9%), whereas, 
the cerebellum (-41%) was the least affected region. This indi-
cates that each region has its own vulnerability towards 
metasystox toxicosis. Results of the present study indicate 
that metasystox administration causes significant dose-dependent 
depletion in the concentration of DNA. Similarly, a dose-related 
diminution in the content of DNA after organophosphate dichlorvos 
intoxication was observed by Paolo and Fini (1950). The 
diminution in the concentration of DNA by organophsophate 
metasystox also supports the already reported (Dean, 1972) 
depletion in the level of Wk following organophosphate dichlorvos 
treatment on cultured human lymphocytes. Among the likely 
reasons for this diminution may be the degeneration of neurons 
and nerve fibres as reported in organophosphate, DDVP toxicosis 
(Hasan et al., 1979), in connection with increased lipid 
peroxidation (Hasan and Ali, 1981). It has also been reported 
that organophosphates chronnatolyse the neurons in chick 
(Janzik and Glees, 1966). In addition to this, the reduction 
in ENA level may be attributed to the increased nslase activity, 
in the brain regions of rat treated with metasystox, as suggested 
by Tayyaba et al. (1981). The significantly increased activity 
of EWase in various regions of brain reported in the present 
study correlates well with the decrement in the DNA. Since 
brain is a heterogeneous tissue both anatomically and functionally 
this heterogeneity is important for the evaluation and inter-
pretation of biochemical findings (Hertz, 1969). It is con-
ceivable that different modes of degradation might be operative 
in different regions of brain. 
4•€*0 Metasvstox-Induced Alterations in the Concentration of 
Ribonucleic acid (RNA) and the Activity of Ribonucleic 
Enzymes (RNase) 
The RNA concentration exhibited regional heterogeneity 
in the control as well as experimental animals. Interestingly, 
the RNA level of the cerebral hemisphere was decreased whereas, 
it was increased in all the other regions of the brain. However, 
the response of RNA to metasystox intoxication is different from 
DMA response in that the former increases in most of the regions 
while later decreases. Thus the effect of metasystox on RNA 
cannot be compared with ENA and this may be due to the changes 
in the activity of enzymes which controls the synthesis and 
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turnover of nucleic acids. 
However, the increment of BNA is not uniform in various 
regions. In all the regions, except cerebral hemisphere, the 
RNA level reaches maximum at the dose of 4 mg/kg body weight. 
The minimum increase (70.27%) of RNA level has been noticed 
in cerebellum. These differences may be due to functional 
heterogeneity in connection with rate of protein synthesis among 
the various brain regions. 
The increment in RNA concentration due to organophosphate 
•toxicosis has been explained by Tamilvanan (1984). Elevation in 
the concentration of RNA has also been shown in the various brain 
regions of the phosalone poisoned rats (Kirubagaran, 1984; 
Palanivelu, 1984). The available literature on nucleic acids 
indicates that the knowledge pertaining to organophosphate 
toxicity on brain nucleic acids and enzymes is inadequate. It 
has been demonstrated that RNA synthesis increases due to damage 
of the neurons, in which the RNA level remains high between 10 to 
30 days after which it returns to normal level (Mcllwain and 
Bachelard, 1971). In metasystox treated rats, the increase of 
RNA concentration at sub-lethal dosage (4 mg/kg body weight) was 
upto 1505^  which is paralleled with RNase activity (Tayyaba et al., 
1981). The increment of RNA level in brain of dieldrin-fed rats 
has also been reported by Bergen (1972). 
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Demyelination is a feature of poisoning by many organo-
phosphate pesticides and that results in the increased production 
of RNA {Heath, 1961; Mcllwain and Bachelard, 1971). The elevation 
in the level of RNA is generally associated with the improvements 
in protein nutrition or tissue function (Bergen et al., 1974). 
Hence, the enhanced level of RNA content in the different regions 
of the brain suggests that selective synthesis of proteins might 
have occurred under stress condition (Prosser, 1969). 
4»7.0 Metasystox-Induced Alternations in the Level of Protein 
The total protein level was understandably depleted in all 
the regions except the cerebral hemisphere where significant 
alteration was not detected. As in the other parameters, here 
also the maximum decrease has been observed at the dose of 
4 rag/kg body weight. It has been reported by Ravi (1984) that 
organophosphate-phosalone induces reduction in the protein concen-
tration in the various brain regions of the fishes Labio rohita 
and Cyprinus carpio. The changes in the neuronal activity are 
accompanied by measureable changes in macromolecules like protein 
in brain cell. It has also been reported that the increased 
neuronal activity decreases or inhibits the synthesis of proteins 
(Hyden and Lange, 1972). The specific neuronal functions, such 
as conduction of action potentials and synaptic transmission are 
extensively mediated by proteins (Bock, 1978). It has been 
evidenced that many environmental and nutritional factors may 
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bring about the changes in the brain proteins (Mcllwain and 
Bachelard, 1971). The decrement in the protein concentration 
in many regions of the brain, except in cerebral hemisphere and 
spinal cord has been observed in the rats treated with sublethal 
dose of metasystox, an organophosphate (Tayyaba et al», 1981). 
Identical trend has been observed in the brain regions of the 
phosalon treated rats (Kirubagaran, 1984; Palanivelu, 1984;. 
Tamilvanan, 1984). Sublethal studies in fish, Talapia mossambica 
with dichlorvos, an organophosphate pesticide have also indicated 
significant decrease in the levels of protein concomitant with 
n^ A and RNA {Rath and Misra, 1980). Ahmad et al. (1978) are of 
the .opinion that the decrement of protein is due to increased 
proteolytic activity that occurs to meet the energy demands under 
toxic stress. Interestingly, all these findings of the present 
work could be explained on the basis of higher utilization of 
protein leading to the reduction of protein content due to 
increased proteolytic activity. The RNA content indicates the 
intensity of protein synthesis in a tissue (Brachet, 1955). Hence, 
the increased level of RNA in the present investigation suggests 
the non-interference of metasystox directly in the protein 
sysnthesis. 
The decrement of protein despite its normal synthesis 
suggests higher rate of utilization than the rate of synthesis 
of protein due to metasystox poisoning. Free amino acids in 
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brain are known to be involved in a number of metabolic 
processes (Neame, 1968). Hence the increased demand for 
amino acids possibly induces the break-down proteins and 
this could have enabled the animal to withstand the toxic 
stress by performing normal neurochemical functions. 
4.6.0 Analysis of Variance 
Analysis of variance indicated that the total variation 
within different regions of the brain is significant. Moreover, 
metasystox-intoxication exerted remarkable effect on lipid 
levels of the rat brain. 
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7 •O INDEX OF ABBREVIATIONS USED 
AiNlSA : 1- Amino -2- Nephthol-4- Sulfonic Acid 
ANOVA: Analysis of variance 
CMS ; Central Nervous System 
C/P : Cholesterol/Phospholipids 
DDW : Double Distilled Water 
DNA: Deoxyribonucleic Acid 
DNase: Deoxyribonuclease 
RNA : Ribonucleic Acid 
H^ase: Ribonuclease 
TEA : ThlobarbitHric Acid 
TCA : Trichloroacetic Acid 
